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DIABETIC CORONARY HEART PATIENTS' ADHERENCE TO CARDIAC 
REHABILITATION PROGRAMS 
 
Joyce Kathleen Miketic, MBA, RN 
University of Pittsburgh, 2011
 
Background: Enrollment in cardiac rehabilitation programs (CR) is used to help patients with 
coronary artery disease alone (CAD) and diabetes mellitus plus coronary artery disease 
(T2DM+CAD) regain function after coronary artery bypass grafting (CABG), but T2DM+CAD 
patients show less functional improvement and lower CR adherence for unknown reasons. The 
“Patient-by-Treatment Context Interaction in Disease Model” may provide a framework for 
explaining how disease and intrapersonal factors impact outcomes of these patients.  
Objective: To explore potential differences in patient profiles and illness contextual factors 
between CAD and T2DM+CAD subjects at CR entry, and in adherence and outcomes at CR 
conclusion. 
Methods: This prospective descriptive pilot study recruited 51 CR subjects (27 CAD; 24 
T2DM+CAD) and measured patient profiles (socio-demographics, personality traits, locus of 
control, coping, social support, exercise efficacy) and illness contextual factors (specific disease 
stage, illness severity, treatment complexity, comorbidities) at CR entry, and appointment and 
medication adherence, functional status and illness severity at CR conclusion, using questionnaires, 
point-of-care testing, and medical record information.  
Results: There were no statistically significant differences in patient profiles and illness 
contextual factors between the CAD and T2DM+CAD cohorts, but there were clinically 
meaningful trends regarding age and gender (T2DM+CAD younger and more female), profiles 
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(CAD more conscientious; T2DM+CAD more adaptive coping, less exercise efficacy) and 
illness severity (T2DM+CAD fewer bypasses but lower ejection fraction, many CAD subjects 
were pre-diabetic). There were no statistically significant differences between cohorts in 
attendance, medication adherence and functional outcomes at CR conclusion, but the 
T2DM+CAD cohort reported  need for  more functional assistance at both time points; neither 
cohort improved their illness severity.  
Conclusions: Although patient profiles and illness contextual factors of CAD and T2DM+CAD 
subjects in a CR program were statistically similar, some clinically meaningful trends were noted 
that are worthy of future investigation to inform CR care. 
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1.0  INTRODUCTION 
The Healthy People 2010 Physical Activity Health Indicator currently reveals that 11% or 23.5 
million working age adults 20 years and older have been diagnosed with both coronary artery 
disease (CAD) and type 2 diabetes mellitus (T2DM), with estimates that an additional 9% of the 
total United States population will be diagnosed with this dual disease combination by the year 2025 
(Boyle, 2001; National Center for Chronic Disease Prevention and Health, 2008).  Projected health 
care costs for this working age population, including direct medical care costs and indirect costs 
(physical and psychological disabilities, work loss, premature mortality), will exceed $620 billion 
U.S. (Boyle, 2001). Moreover, the risk of developing a myocardial infarction (MI) is 2-4 times 
greater in these individuals as compared to individuals diagnosed only with CAD (ADA, 2003; 
Mayfield, 1999). Several studies have confirmed that 25% to 32% of all patients with MI requiring 
a revascularization procedure have both CAD and T2DM (Flaherty, 2005; Hindman, 2005). 
 When patients undergo a revascularization procedure such as a coronary artery bypass graft 
(CABG), the primary intervention prescribed for these patients to regain functional ability 
afterwards is enrollment in a standard outpatient cardiac rehabilitation program (CR). These 
programs, ranging in duration from 6 to 12 weeks, have been shown to improve the physical 
function of CAD patients by up to 15%, but patients diagnosed with the chronic disease states of 
T2DM+CAD exhibit only an 8% improvement (Egede, 2004; Hindman, 2005; Verges, 2004). 
Likewise, many research investigations have corroborated that T2DM+CAD patients experience 
much lower rates of cardiac rehabilitation program appointment adherence and greater attrition (45-
62% T2DM+CAD vs. 92% CAD) (Egede, 2004; Hindman, 2005; Mayfield, 1999; Verges, 2004). 
 The specific causes for lower cardiac rehabilitation program appointment adherence and 
poorer rehabilitation program outcomes for T2DM+CAD patients are still unknown. The “Patient-
by-Treatment Context Interaction in Chronic Disease Model” developed by Dr. Alan Christensen 
provides direction for understanding how the multiplicity of individual disease perceptions and 
intrapersonal factors interact to impact treatment adherence (Christensen, 2000). The primary 
assumption of this behavioral-based model is that by analyzing specific patient profiles 
(sociodemographics, personality traits, locus of control, coping strategies, social support, and 
treatment efficacy) in relationship to relevant patients illness contextual factors (specific disease 
stage, illness severity levels, treatment regimen complexity and co-morbidities), individualized 
interventions can be designed to improve treatment adherence rates, and therefore treatment 
outcomes (Christensen, 1997; Christensen, 2000). 
 Therefore, the primary purpose of this prospective, descriptive pilot study was to use 
Christiansen’s “Patient-By-Treatment Context Interaction in Chronic Disease Model” to explore if 
differences exist between the patients profiles and illness contextual factors of patients with CAD 
only and T2DM+CAD  at entry to a standard outpatient cardiac rehabilitation program after CABG, 
as well as potential differences in program adherence and outcomes at program conclusion. 
Understanding these potential differences will provide pilot data to establish reasons why 
T2DM+CAD patients have poorer program adherence and outcomes, and if cardiac rehabilitation 
interventions adjusted to their specific profiles and factors would be beneficial.  
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1.1 SPECIFIC AIMS 
The specific aims of this pilot study were to: 
(1) Explore differences in patient profiles (sociodemographics, personality traits, locus of 
control, coping strategies, social support, and exercise treatment efficacy) between T2DM+CAD 
and CAD patients at entry to a standard outpatient cardiac rehabilitation program. 
(2) Explore differences in illness contextual factors (specific disease stage, illness severity 
levels, treatment regimen complexity, and co-morbidities) between T2DM+CAD and CAD patients 
at entry to a standard outpatient cardiac rehabilitation program.  
 (3) Explore differences in program adherence (appointment attendance and medication 
adherence) and outcomes (changes in functional status and illness severity markers) between 
T2DM+CAD and CAD patients upon conclusion of a standard outpatient cardiac rehabilitation 
program. 
(4)  Explore the main and interaction effects of both the patient profiles and illness 
contextual factors within the T2DM+CAD and CAD patients groups on program adherence 
(appointment attendance and medication adherence) and outcomes (appointment attendance and 
medication adherence) upon conclusion of a standard outpatient cardiac rehabilitation program.  
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1.2 REVIEW OF LITERATURE 
 
Miketic JK, Hravnak M, Stilley CS, Robertson RJ, Sereika SM. (2011) Factors Influencing the 
Outcomes of Patients With Both Coronary Artery Disease and Diabetes Enrolled in Standard 
Cardiac Rehabilitation Programs: A Literature Review. Journal of Cardiovascular Nursing 
May/June; 26:210-217. 
 
The copyright approval letter to use this manuscript in this dissertation may be found on page 79 
of Appendix A. 
1.2.1 Abstract 
Currently 23.5 million working age adults 20 years and older have been diagnosed with both 
coronary artery disease and type 2 diabetes mellitus with estimates that an additional 9% of the 
total United States population will be diagnosed with this chronic disease combination by the 
year 2025. Current annual health care costs for this working age population including medical 
costs, functional disability, work loss, and premature mortality currently exceed $620 billion. 
Prior research efforts have shown that 25% to 32% of patients requiring a coronary 
revascularization procedure have both coronary artery disease and type 2 diabetes mellitus. The 
primary intervention prescribed for these patients to regain functional ability after 
revascularization is enrollment in a standard outpatient cardiac rehabilitation program (CR). 
These standard programs, ranging in duration from 6 to 12 weeks, have been shown to improve 
the physical function of coronary artery disease (CAD) patients by up to 15%, but patients 
diagnosed with both chronic conditions of coronary artery disease and type 2 diabetes mellitus 
(T2DM+CAD) attending these same programs exhibit only an 8% improvement. Moreover, 
T2DM+CAD patients experience much lower rates of rehabilitation program appointment 
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adherence as well as greater program attrition (45-62% T2DM+CAD vs. 92% CAD). Current 
literature regarding the relationship between CAD, T2DM, and CR will be examined to identify 
specific factors that could influence the functional outcomes achieved by the T2DM+CAD 
population when enrolled in a standard CR program and help increase understanding of why the 
adherence and attrition differences exist. 
 
1.2.2 Prevalence of Type 2 Diabetes Mellitus and Coronary Artery Disease 
According to the American Diabetes Association’s 2010 position statement, diabetes is a chronic 
condition that continues to influence both major public health and economic issues in the United 
States (ADA, 2010; Songer, 1998). Due to lifestyle preferences that promote physical inactivity 
and increasing rates of obesity, the number of Americans diagnosed with the most prevalent 
form of diabetes mellitus (Type 2 or Adult onset) is projected to increase from 21 million to 29 
million in 2050 (ADA, 2003; Boyle, 2001; U.S. Department of Health and Human Services, 
2008). 
 The underlying causes of type 2 diabetes mellitus (T2DM) result from a combination of 
impairment in insulin-mediated glucose disposal and insulin secretion by pancreatic beta cells 
(Grundy, 2002; Bergenstal, 2007).
 
T2DM, if left untreated, has been shown to be a strong 
contributor in the development of CAD (Grundy, 2002; Bergenstal, 2007).
 
The Healthy People 
2010 Physical Activity Health Indicator currently reveals that 11% or 23.5 million working age 
adults 20 years and older have been diagnosed with both CAD and T2DM, with estimates that an 
additional 9% of the total United States population will be diagnosed with this dual disease 
combination by the year 2025 (Egede, 2002; National Center for Chronic Disease Prevention and 
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Health, 2008, National Center for Health Statistics, 2008). Projected health care costs for this 
working age population, including direct medical care costs and indirect costs (disability, work 
loss, premature mortality), currently exceeds $620 billion U.S. (Bergenstal, 2007).
 
The risk of 
developing a myocardial infarction (MI) is 2-4 times greater in these individuals as compared to 
individuals diagnosed only with CAD (Sahakyan, 2006).
  There is also evidence that although 
the overall CAD mortality rates have decreased in the total United States population, CAD 
mortality is not declining in the DM population (Gu, 1999). 
 
Several studies have confirmed that 
25% to 32% of all patients with MI requiring a revascularization procedure have both CAD and 
T2DM (Sahakyan, 2006; Julien, 1997). 
 The primary intervention prescribed for these patients to regain functional ability after 
revascularization is enrollment in a standard outpatient cardiac rehabilitation program. These 
programs, ranging in duration from 6 to 12 weeks, have been shown to improve the physical 
function of CAD patients by up to 15% but, patients diagnosed with both chronic disease states 
of T2DM+CAD exhibit only an 8% improvement (Egede,2004). Moreover, many research 
investigations have corroborated that T2DM+CAD patients experience much lower rates of 
rehabilitation program appointment adherence and greater attrition (45-62% T2DM+CAD vs. 
92% CAD) (Egede,2004;Hindman,2005;Verges,2004). Therefore, the purpose of this 
T2DM+CAD literature review is to enhance the nurses’ understanding of potential factors that 
may influence this unique population’s functional outcomes prior to and after enrollment in a 
tandard cardiac rehabilitation program.  s
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1.2.3  Review of Literature Method 
Original articles published in the English language were identified through an OVID and 
Medline literature search conducted for the years of 1996 to 2010. The following key terms were 
utilized alone or in combination for the specific literature search: diabetes mellitus, type 2 
diabetes mellitus, cardiovascular disease, coronary artery disease, cardiac rehabilitation, 
functional outcomes, disability, physical activity, adherence, revascularization and coronary 
artery bypass graft.  
 All the articles examined were studies based on exploring some aspect of the relationship 
between coronary heart disease, type 2 diabetes mellitus and cardiac rehabilitation. Since only 
English translated research articles were examined, this literature review may have missed some 
documentation discussing significant findings between the combined CAD, T2DM+CAD and 
CR evidenced from foreign medical research investigations. In addition, recent position papers 
on diabetes and cardiovascular disease were reviewed to provide a comprehension review of the 
current medical standards of care for both the CAD and T2DM patient population. From this 
literature search, four major areas appeared to emerge concerning the relationship between 
coronary heart disease, type 2 diabetes mellitus and cardiac rehabilitation. The first area was the 
relationship investigated between the concept of overall functional disabilities and the chronic 
disease state of T2DM. The second area was research involving the examination of the 
association of exercise and T2DM. The third area included exploration in the pathophysiological 
patterns present in patients with T2DM+CAD. The final area, which yielded the smallest 
percentage of research articles, was an inquiry into documented outcomes of T2DM+CAD in 
cardiac rehabilitation programs. 
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1.2.4 Functional Disability and Type 2 Diabetes Mellitus 
Functional disability defined as difficulty performing daily living, routine social or work related 
activities is highly prevalent in individuals diagnosed with chronic diseases such as diabetes 
mellitus (Gregg, 2000).
 
Several studies conducted between 1999 and 2005 investigated this 
specific functional relationship between T2DM and disability.  
Gregg found in his analysis of the Third National Health and Nutrition Examination 
Survey (NHANES III) data that 1.2 million U.S. adults (one-fourth of population from the 
NHANES sample) were diagnosed with T2DM and unable to do simple mobility tasks defined as 
walking one-fourth of a mile (Gregg, 2000).
  Moreover, the NHANES T2DM population 
demonstrated slower walking speeds, chair-stand performances and balance positioning abilities 
(Gregg, 2000). 
 
Gregg associated the decline in these higher physical activities to be due to both 
diabetic complications (retinopathy and neuropathy) and associated coronary heart disease co-
morbidities such as microvascular disease (Gregg, 2000). 
Gregg later went on to utilize data from a study of Osteoporotic Fractures, in which he 
analyzed both intrinsic (obesity, hyperglycemia) and extrinsic (coronary heart disease, peripheral 
vascular disease) factors to determine the extent of functional disability in older women with 
T2DM (Gregg, 2002). 
 
This specific research investigation demonstrated that the development of 
functional disabilities in performing routine bathing, dressing or low impact mobility tasks was 
doubled (10%) for women with T2DM as compared to women without T2DM (5%) caused by 
socio-demographic classification and access to healthcare (Gregg, 2002).
 
Blaum’s research classified older adults into high, intermediate and low functioning 
individuals diagnosed with and without T2DM and followed their performance activity levels for 
two years (Blaum, 2003). Data were obtained from the Study of Assets and Health Dynamics 
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among the Oldest Old (AHEAD), a longitudinal study of a nationally representative cohort of 
persons aged 70 and older living in a community setting (Blaum, 2003).
  
High functioning 
individuals were defined as reporting no limitations in tasks involving Physical Functioning 
Tasks (walking several blocks, climbing one flight of stairs, lifting 10 pounds) Instrumental 
Activities of Daily Living Tasks (taking medications, using the telephone, managing money) and 
Personal Care Tasks (dressing, bathing, toileting, eating) (Blaum, 2003).
 
Thirty-nine percent of 
this population had T2DM. Intermediate functioning adults demonstrated difficulties in two of 
the three functional categories with T2DM’s comprising 36% of the total intermediate population 
(Blaum, 2003). 
 
Low functioning adults reported limitations in all three functioning categories 
and as expected in the sample size calculation, 24% of adults were diagnosed with T2DM 
(Blaum, 2003).  This two-year investigation revealed that 25% of T2DM adults continued to 
enjoy high functioning status but showed a significantly higher rate for the development of 
cardiovascular disease than people without DM (Blaum, 2003). The characteristics of this high 
functioning T2DM group revealed that they were younger, had a higher educational level and 
had better access to chronic disease care allowing them to practice preventative disease 
behaviors as prescribed by their health care team (Blaum, 2003). Those T2DM subjects who 
were initially defined as low functioning exhibited minor changes in their functional status for 
the two year study participation time whereas, intermediate functioning adults displayed the 
greatest change in routinely performing all required physical functioning, instrumental activities 
of daily living, and personal care tasks (Blaum, 2003).
  
Two notable conclusions can be drawn from this study. First, the non-decline in 
functional status for high functioning diabetics may be related to the good preventative 
healthcare practices of this group. Secondly, the decline in the intermediate functioning 
21 
population may be correlated with the progressive development of complications associated with 
microvascular degeneration and associated co-morbidities such as CAD (Blaum, 2003). Research 
by Egede focused on the connection between functional disability, T2DM and depression. Data 
used in this study came from the National Health Interview Survey (NHIS) (Egede, 2004). 
 
Several important conclusions resulted from this study. Individuals with T2DM developed major 
depressive episodes at more than two times greater the rate (58.1%) than individuals without DM 
(24.5%) (Egede, 2004). 
 
T2DM subjects with other co-morbidities such as CAD or congestive 
heart failure developed major depressive episodes at three times the rate (77.8%) compared to 
non-diabetic individuals (Egede, 2004).
 
A study that confirms Egede’s findings that depressive 
illness is strongly associated with disease complications and work disability was conducted by 
Von Koref (Von Koref, 2005). 
 
Twenty-four percent of his enrolled T2DM subjects reported that 
they had experienced either a minor or major depressive episode with 19% indicating that the 
depressive incident resulted in significant work disabilities (defined as missing greater than 5 
days of work per month) (Von Koref, 2005). 
Continuing with the investigational theme of functional disability, Mayfield’s research 
used data obtained from the National Medical Expenditures Survey-2 (NMES), and investigated 
the sole concept of “Work Disability” in T2DM (Mayfield, 1999). This form of disability was 
defined as a complex interaction of health conditions, functional status, special work 
requirements and available economic alternatives (Mayfield, 1999). 
 
Thirty percent of the women 
with T2DM were classified as work disabled (Mayfield, 1999).
 
In addition, work disability or 
functional impairment rates between male and female diabetics were found to differ by only 5% 
(Mayfield, 1999). 
 
However, Sanderson’s research reported that the main deterrent preventing 
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women from attending a CR program was low income and education, not disability (Sanderson, 
2010).  
Therefore, these studies on the functional disabilities of patients with T2DM clearly 
indicate some of the profound and detrimental influences (preventative health practices, socio-
demographic status, gender and education) that eventually lead to the chronic disease 
complications and comorbid disease progressions that cause T2DM individuals to be eventually 
lassified as severely impaired. c
 
1.2.5 Exercise and T2DM 
The American Diabetes Association and the American College of Cardiology issued a combined 
statement about the benefits of T2DM individuals participating in routine exercise programs. 
Diabetics who regularly engage in physical activity improve their glycemic control by 
stimulating glucose utilization and improving insulin sensitivity and glucose uptake in muscles 
resulting in a decline in blood glucose (ADA, 2004). 
 
A single bout of aerobic exercise on insulin 
sensitivity may last as long as 24-72 hours and reduce HbA1C levels by 0.66% (ADA, 2004; 
ACC, 2004). 
 
Physically active diabetics also have been shown to exhibit lower blood pressures 
readings, increased HDL cholesterol levels, decreased triglyceride levels, plus decreased anxiety 
and depression episodes (Cauza, 2006; Chipkin, 2001; Eyre, 2004; Tekin, 2006). These factors 
are favorable to not only protect diabetics against the development of diabetic complications, but 
also cardiovascular disease as well.  
The position on exercise activity for diabetics was developed by examining the results of 
current studies such as Loimaala’s 2003 investigation on the effects of exercise training on 
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glycemic control, cardiovascular performance and systemic vascular resistance in T2DM 
population. This study showed that T2DM subjects who completed a 52-week endurance 
exercise program, improved their maximal oxygen consumption level by 2.3%, decreased their 
HbA1C values from 8.2 to 7.5%, and increased muscle strength and exercise capacities 
(measured by performing sit-ups and leg extensions exercises) by 7.7% (Loimaala, 2003).
 
 
 
Sigal’s research contributed to the importance of exercise for the T2DM subject by 
focusing on investigating the physical effects of aerobic training alone, resistance training alone, 
and the combined aerobic/ resistance exercise on HbA1C levels (Sigal, 2007).
 
The investigator 
stated that a 1% decrease in HbA1C values can be associated with a 15% to 20% decrease in 
developing a major cardiovascular event and a 37% reduction in microvascular complications 
(Sigal, 2007).
 
This study concluded that participation in either aerobic or resistance training can 
positively change overall HbA1C values (8.1% Aerobic vs. 18.9% Resistance) (Sigal, 2007). 
 
However, the greatest change in these HbA1C levels (20.3%) occurred when subjects 
participated in a combined aerobic/ resistance training program (Sigal, 2007). 
Gender and social demographics also exhibit a noteworthy effect on the physical activity 
behavior patterns of the T2DM population. Research performed in 2007 on data derived from the 
Alberta Longitudinal Exercise and Diabetes Research Advancement (ALEXANDRA) study 
revealed that T2DM men participated in more exercise activities than women (Barrett, 2007). 
 
Furthermore, these men were better educated and had substantially larger sources of income 
which allowed them to partake of more leisure time physical activities such as jogging, hiking, 
aerobics classes, strength training and sports (Barrett, 2007). 
 
In contrast, T2DM women were 
more likely to have low-incomes and categorize their primary physical activities as walking 
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while performing errands or performing routine household duties (Barrett, 2007). 
 
This study also 
concluded that the best activity to promote exercise in all gender and socio-demographic T2DM 
segments is walking (Barrett, 2007). In addition, the ALEXANDRA study researchers concluded 
that employers may consider providing fitness centers emphasizing health prevention and 
physical activity classes in the workplace so as to make exercise a more convenient activity for 
younger working class individuals with T2DM (Barrett, 2007). 
  
 
 In summary, these exercise based research efforts for T2DM individuals 
concurred in demonstrating that all forms of physical activity, including the simple act of 
walking, can both improve diabetic control as well as reduce both future diabetic and 
cardiovascular complications. 
1.2.6 Pathophysiological Patterns with T2DM+CAD 
The American Heart Association describes T2DM primarily as a cardiovascular based disease 
(Grundy, 2002; Rosano, 2006). 
 
Recent research efforts have identified that specific clustering of 
independent cardiovascular risk factors, like dyslipidemia and hypertension, combined with 
changes in prothrombotic factors, such as increased fibrinogen and plasminogen activator 
inhibitor-1 levels, increase the likelihood of the affected individuals being diagnosed with cardio 
metabolic or insulin resistance syndrome (Grundy, 2002; Rosano, 2006). 
  
 
Moreover, the microvascular complications resulting from this syndrome not only can 
lead to diabetic complications such as peripheral neuropathy, but also are associated with 
increased rates of mortality and morbidity (Rosano, 2006).
 
 
Investigators have demonstrated that the poor prognosis witnessed in the T2DM+CAD 
population may be caused by a combination of enhanced myocardial dysfunction and accelerated 
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atherogenesis involving the distal coronary segments, resulting in congestive heart failure and 
cardiovascular collapse (George, 2001; Julien, 1997).  Therefore, patients with major coronary 
artery occlusion are likely to also have more advanced microvascular disease. Interestingly, 
several research investigations have demonstrated that the extent of the atherosclerosis process 
present in a T2DM+CAD person can be positively or negatively enhanced by the individual’s 
self-initiated behaviors of monitoring blood pressure levels, eliminating smoking habits and 
maintaining recommended waist-girth patterns (George, 2001; Grundy,1999). 
An interesting study performed by Bowden in 2006, increased understanding of the 
genetic relationship between cardiovascular disease and T2DM. After conducting careful 
analysis on 1079 genotypes from concordant siblings in the North Carolina, this Diabetes Heart 
Investigation determined that chromosome 3p was the probable source of a linkage existing 
between T2DM, Cardiometabolic syndrome and CAD (Bowden, 2006). 
 
Future research efforts 
on this chromosome to substantiate this genetic clue as the link between CAD and DM will be 
necessary to substantiate this important finding.  
Two other studies were identified which examined the relationships between T2DM and 
cardiovascular symptom management. Rachmani’s study examined if shared therapeutic 
responsibility between T2DM+CAD patients and their health care provider retarded the 
progression of both micro-and macrovascular complications (Rachmani, 2002). 
 
Results showed 
that patients who did not maintain a proactive association with their primary health provider had 
higher HbA1C values (8.9% proactive group vs. 8.2% standard group), higher LDL levels (124 
mg/dl proactive group vs. 114 mg/dl standard group), and a higher incidence of developing 
cardiovascular related events (36 proactive provider group versus 23 standard relationship group) 
(Rachmani, 2002). 
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 Saydah’s work assessed the effectiveness of standard medical care for controlling risk 
factors for vascular disease in T2DM patients. Like Gregg, her primary data source came from 
the Third National Health and Nutrition Examination Survey (NHANES) (Saydah, 2004). 
 
She 
compared data on T2DM+ CAD subjects collected from both the NHANES and NHANES III 
investigations. In looking at these comparisons of standardized treatment recommendations for 
control of vascular complications, she chose to analyze HbA1C, blood pressure and total serum 
cholesterol levels. The overall mean value HbA1C levels did not change over time from the 
NHANES (7.7%) to NHANES III (7.6%)—a span of 12 years (Saydah, 2004).
 
Additionally, the 
overall mean blood pressure values did not substantially change from the NHANES (138/74 mm 
Hg) to NHANES III (131/73 mmHg) (Saydah, 2004). 
 
However, 66.1% of NHANES subjects 
had cholesterol levels over 200 mg/dl as compared to 52% of subjects from the NHANES III 
study (Saydah, 2004). 
 
Thus, she concluded that medical treatment practice patterns changes for 
the prevention of vascular disease in T2DM patients had only been changed slightly over time, 
and that further health efforts are needed to control risk factors for cardiovascular disease among 
individuals diagnosed with T2DM (Saydah, 2004). 
In addition to the NHANES study, Mehler investigated the adequacy of treatment of 
hyperlipidemia in patients with T2DM enrolled in the Appropriate Blood Pressure Control in 
Diabetes trial (Mehler, 2003). 
 
He found that Only 19% of the 133 patients with known coronary 
artery disease had an LDL cholesterol level less than 100 mg/dL at baseline, and only 16% 
achieved this level at the completion of the study (p = 0.37) suggesting that hyperlipidemia is 
being treated sub optimally in this combined chronic disease population (Mehler, 2003).
  
In summary , these research articles on the pathophysiological patterns in T2DM+CAD 
research have validated the synergistic link between these two chronic disease states, but further 
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efforts must be made to implement health treatment changes for these conditions by the health 
care community. 
1.2.7  CR Program Outcomes in Patients with T2DM+CAD 
Coronary Artery Bypass Grafting (CABG) or coronary revascularization has been the treatment 
of choice to correct the atherosclerosis complications present in the T2DM population as 
evidenced by several studies. However, limited research studies have been performed on how to 
achieve a successful rehabilitation recovery in this specialized patient population.  
 Pennell emphasized that a successful outcome after coronary artery bypass graft starts 
with pre-surgical treatment practices such as implementing a strict glycemic initiative. (Pennell, 
2005)
 
Using data collected on 103 Post-CABG patients in Eastern United State hospital, Pennell 
found that by utilizing a glycemic practice plan, the length of stay for the T2DM+CAD patients 
was reduced by 1.2 days, 6.7% of the T2DM+CAD patients developed post-operative infections 
and only 2 patients died (Pennell, 2005).  
Along the same research outcome focus of glycemic control, Verges enrolled 59 T2DM 
patients in a 2-month cardiac rehabilitation program to determine if these diabetic patients could 
obtain an increase in exercise capacity (maximal oxygen consumption =V02 max) as non-
diabetics post revascularization procedure (Verges, 2004).
   
He found no significant pre-cardiac 
program differences existed between the T2DM and Non-DM groups in terms of left ventricular 
function, type of coronary event, site of MI, use of cardiovascular drugs, prevalence of 
hypertension and smoking history (Verges, 2004). 
 
However, the body mass index (BMI) was 
slightly higher in the T2DM group as compared to the Non-DM (28.3 kg/mvs. 24.9 kg/m) 
(Verges, 2004). After completion of the rehabilitation program, Verges found that changes in 
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peak V02 max for the diabetic group was significantly and inversely correlated with their fasting 
blood glucose levels, i.e. the lower the blood glucose the higher the exercise capacity (r = 0.40, p 
=0.002) (Verges, 2004).
 
He therefore concluded that the response to cardiac rehabilitation by 
T2DM patients may be influenced by blood glucose levels (Verges, 2004). 
Yu’s research continued this focus on glycemic control outcomes of T2DM patients 
participating in cardiac rehabilitation exercise programs (Yu, 2000). In a cohort of 418 patients 
enrolled in CR, the mean age was 64 years, 32% were diagnosed with T2DM, 70% of enrolled 
subjects were male and 49% were diagnosed with hypertension (Yu, 2000).
  
His results showed 
that the re-hospitalization rate for T2DM+CAD patients was significantly longer than for CAD 
only patients (2.3 days T2DM+CAD vs. 1.6 days CAD, p=0.04), hospitalization length of stay 
was doubled (25.5 days T2DM+CAD vs. 11.4days CAD, p=0.02), and a significant trend was 
noted toward increasing fasting blood sugar levels for the T2DM+CAD patient as their 
participation in the CR program progressed (7.9 mmol T2DM Pre-CR vs. 9.0 mmol T2DM 
Post=CR, p=0.11) (Yu, 2000). 
 
However, no change in glucose levels in the CAD only 
population was present. (5.4 mmol Non-DM Pre-CR vs. 5.4 mmol Non-DM Post=CR, p=0.23) 
(Yu, 2000).
  
So, based on Yu’s study results, it is recommended that strict glycemic monitoring 
of T2DM patients during CR be initiated (Yu, 2000). 
Dylewicz’s studies promoted short term endurance training consisting of bouts of cycling 
for his research on glycemic control in the post-CABG T2DM population. His premise was this 
exercise would modify the carbohydrate metabolism due to the increase in binding and 
degradation of the I-insulin erythrocyte receptors will decrease insulin resistance (Dylewicz, 
2000). Results from this study found that his hypothesis was correct. Blood glucose levels 
dropped from 111.2 pre-CR exercises to 97.8 mg/dl post-CR exercises (Dylewicz, 2000).
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Moreover, an increase in insulin binding was noted 0.535 pg to 0.668 pg (Dylewicz, 2000).
  
He 
concluded that CR programs designed with short-term endurance exercise induced favorable 
changes in glycemic control in the T2DM population (Dylewicz, 2000).
  
Banzer’s research on the characteristics of cardiac rehabilitation in patients with T2DM 
addressed the adherence to CR program issue (Banzer, 2004). 
 
In an investigation on 952 patients 
enrolled in a 10 week CR program, he found 26% of the population was diagnosed with T2DM 
and 53% of these subjects were taking insulin and/or an oral hypoglycemic agent (Banzer, 2004). 
T2DM+CAD patents had a significantly lower exercise capacity at entry than CAD only patients 
(5.7 METS T2DM+CAD vs. 7.0 METS CAD, p<0.00001) (Banzer, 2004). 
 
Body Mass Indices 
of the T2DM+CAD population were also higher than the CAD population (34.1 T2DM+CAD 
vs. 30.8 CAD, p<0.0001) (Banzer, 2004). 
 
Most astonishingly, Post CR program results indicate 
that T2DM+CAD patients had a 62% dropout rate and withdrew from the program more often 
due to an exacerbation of medical problems (Banzer, 2004). 
 
 
Soja’s demonstrated that by using an intense multifactorial intervention that focused upon 
individualized diabetic education sessions, improvements in both exercise capacities and 
reductions in both blood pressure and HbA1C levels resulted in improved post cardiac 
rehabilitation program outcomes for the T2DM+CAD population (Soja, 2007). 
 
In this Danish 
Study of Impaired Glucose Metabolism (DANSUK) study, 104 patients with T2DM+CAD were 
followed in a 1-year intense CR program that consisted of intense nutritional counseling, 
cooking, smoking cessation, psychological support, pharmacological, risk factor management 
and exercise classes (Soja, 2007). 
 
In addition, a 24-hour telephone help-line manned by a trained 
staff was provided as well as consultations with physicians and nurses trained in internal 
medicine and cardiology (Soja, 2007).
 
After the completion of this program, HbA1C levels 
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decreased by 0.65% (p<.05) allowing at least 67% of the enrolled T2DM+CAD patients to reach 
the optimal glycemic goal set at 6.5% HbA1c (Soja, 2007). 
 
Thus, it was determined that an 
intense multipronged CR intervention program is the best method for treating T2DM+CAD 
patients (Soja, 2007).  
Some of the most interesting research on T2DM+CAD patients participating in cardiac 
rehabilitation programs has been conducted by Milani and Lavie. These seasoned researchers 
recognized that T2DM+CAD patients may have long-standing complications such as peripheral 
neuropathy, retinopathy, autonomic neuropathy and peripheral vascular disease. Their research 
revealed, like the DANSUK study, that each of these complications needs to be addressed by an 
individualized cardiac rehabilitation plan (Lavie, 2005; Milani, 1996). For example, they found 
that T2DM+ DM patients with peripheral vascular disease may utilize cycle ergometry and arm 
ergometry exercises to replace the traditional treadmill walking (Mlani, 1996). 
 
In addition, 
Milani and Lavie investigated the psychological behaviors exhibited by T2DM+CAD patients in 
cardiac rehabilitation programs. Diabetics demonstrated a higher incidence of depression 
(T2DM+CAD 26% vs. CAD 14%, p<0.03) (Mlani, 1996). 
  
They concluded that screening for 
depression prior to any active participation in a cardiac rehabilitation program is an essential 
assessment for the T2DM patient (Mlani, 1996). 
  
These findings were interesting because in a 
study conducted by Maniar on the typical CAD focused rehabilitation population, older patients 
with CAD that began a CR program showed higher co-morbidity burdens, but displayed 
decreased depression index scores (Maniar, 2009). 
In a more recently published article, Marout reported that prior to beginning a CR 
program, T2DM patients with CAD showed a higher prevalence of cardiovascular disease risk 
factors such as hypertension and hypercholesterolemia, and overall poorer physical attributes as 
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demonstrated by their body composition measurements than patients with CAD-only patients 
(Marout, 2010).
 
Moreover, rates of depression were higher in the T2DM+ DM group as 
compared to the CAD-only group (Marout, 2010). 
 
But, both patient groups demonstrated 
significant improvements at the end of their CR programs in overall exercise capacities and body 
composition measurements (Marout, 2010).  
In the last study reviewed, Völler followed patients with T2DM +CAD and CAD to 
specifically track the physiological changes that these patients’ exhibit from hospitalization 
through CR program completion (Völler, 2009). 
 
He specifically examined physiological 
characteristics of blood pressure, lipid and glucose levels, and their relationship to specific 
pharmacological and general treatment management standards (Völler, 2009). 
  
He found that 
although improvements were made in reducing hyperlipidemia, hypertension and hyperglycemia 
control was not as successful, nor were hypertension and hyperglycemia being treated according 
to guideline recommendations (Völler, 2009). He concluded that in order to have patients’ 
achieve optimal CR program goals for both T2DM+CAD patients and CAD patients, a multi-
interventional treatment plan consisting of regular physical activity, healthy diet, and guideline-
oriented drug based therapy must be initiated by medical care providers and strictly followed by 
the CR team (Völler, 2009). 
Thus, these research investigations have shown that T2DM patients may start a CR 
program with inadequate glycemic control and poorer physical attributes, but a comprehensive 
individualized education and exercise program conducted by an interdisciplinary team may 
alleviate or prevent further cardiovascular and glycemic complications.  
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1.2.8 Review Limitations and Conclusions 
The main limitation in conducting this review is that few research studies have examined the 
specialized patient population with the dual diseases of CAD and T2DM in the CR setting. Other 
limitations are that some of the reported studies had small participant populations from distinct 
areas and their characteristics may not reflect the general characteristics of the overall CR 
population. Most importantly, many T2DM patients present to a CR program with additional 
medical conditions such as osteoporosis, nephropathy, retinopathy or neuropathy and the effects 
of these co-morbidities in comparison to the typical CAD patient who has not been fully 
investigated in the CR environment. 
 All of these research studies described in the four focus areas indicate that to accurately 
prepare the T2DM+CAD patient for participation in a cardiac rehabilitation program, a total 
understanding of the individual’s physiological, socio-demographic, and psychological dynamic 
patterns must be studied in detail. Thus, the following strategies may be considered to improve 
outcomes for the T2DM+CAD patients: 
(1.) Development of comprehensive pre-CR assessment tools specifying the 
T2DM+CAD patients’ socio-demographic, medical, psychological (depression) and pre-exercise 
conditions.  
(2.) Development of a Cardiac Rehabilitation Interdisciplinary program focusing on 
aggressive glycemic control measures, nutritional plans, and participant-specific short-term 
endurance exercises. 
(3.) Development of medical-work partnerships at both the primary care and 
rehabilitation levels designed to promote overall cardiovascular health in the diabetic and pre-
diabetic populations.  
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(4.) Continued research efforts designed to examine not only how specific diabetic co-
morbid conditions affect overall TD2M+CAD patient’s CR outcomes, but behavioral-based 
variables as well. The implementation of these strategies can be the starting point for both 
improved outcome and treatment adherence goals for this very special T2DM+CAD population.  
1.3 CONCEPTUAL FRAMEWORK 
Research has shown that non-adherence to recommended chronic disease treatment regimens can 
be associated with the development of both short and long term medical complications as well as 
increased mortality and morbidity rates (Bergenstal, 2007). Patients with T2DM+CAD who 
adhere to their treatment plans reduce their risk for future functional complications (Renders, 
2001). Research has demonstrated also that adherence to particular treatment plans can be 
directly correlated with the patient’s concept of self-care management. As described in several 
scientific investigations, T2DM+CAD patients who developed cooperative relationships with 
their health care provider and became active partners in their treatment plan, improved their 
adherence to care rates by 13 to 25% (Koenigsberg, 2004). 
According to Dr. Alan Christensen from the University of Iowa, most adherence research 
studies on chronic disease illness populations have generally utilized conceptual frameworks 
based upon the Five-Factor Model of Personality or Health Belief Models (Christensen, 2000). 
Christensen and other adherence investigators believe these models are only effective in 
explaining a limited aspect of psychosocial compliance variables (Wiebe, 1997). They fail to 
consider the diversity that exists among chronic disease populations presenting with different 
medical histories, associated comorbidities, sociodemographic circumstances, and treatment 
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plans (Christensen, 1998). Christensen believed that this diversity or “heterogeneity of patients” 
is a combination of psychological, personality and environmental variables and is the essential 
component to analyzing adherence behavioral patterns (Christensen, 2000). Moreover, he further 
hypothesized that the interaction effects of patient profiles with illness contextual factors is the 
dominant influence on adherence expression. Thus, all adherence research efforts should be 
designed around a comprehensive biopsychological assessment approach (Wiebe, 1997).  
Moreover, this type of comprehensive approach could lead to the development of successful 
interventions and thereby improve overall patient adherence to treatment rates. Therefore, 
“Christensen specifically designed “The Patient-by-Treatment Context Interaction in Chronic 
Disease Model,” (Figure 1) to meet this biopsychological gap in adherence research. Christensen 
proved the reliability of his behavioral model in his work with end stage renal patients.  
 
 
 
Figure 1. Christensen’s Patient-by-Treatment Context Interaction in Chronic Disease Model. 
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 The central assumption tested in his model was that relevant illness contextual or 
situational features should be explicitly assessed, and the interaction of these factors with patient 
profile variables should be tested directly. By analyzing both the patient profile and illness 
contextual factors and their interactions in the end stage renal disease patient population, 
Christensen found that subjects who tended to be more internally focused, responded better to self-
directed interventions than healthcare provider directed interventions. He further demonstrated that 
patients possessing a highly active and vigilant style of coping with their health care team 
demonstrated better adherence and adjustment when undergoing more self-directed renal treatment 
plans such as home dialysis or post renal transplantation care. Therefore, Christensen further 
conjectured that as an individual’s chronic disease state progresses and the number of available 
treatment options increases, it becomes increasingly important for health care team members to 
understand the dynamic interactions that ultimately influence adherence patterns.  
As stated earlier, Christensen’s scientific studies were conducted primarily in the end-
stage renal disease population, utilizing a combination of specific renal focused physiological, 
diagnostic, and qualitative measurement tools. This occurred because a key component to this 
model is that measurement devices should be defined in terms of the population being studied 
(Christensen, 2000).  
Thus, “The Patient-by-Treatment Context Interaction in Chronic Disease Model,” is the 
best framework to accomplishment the specific aims of this pilot study, “Diabetic Coronary 
Heart Patients' Adherence to Cardiac Rehabilitation Programs.” Figure 2 illustrates Christensen’s 
model as adapted for this study. Adjusting Patient Profiles and Illness Contextual Factor 
measurments tools to be specific for both patient populations of T2DM+CAD and CAD 
increases the credibility value of all collected data because they have shown relevance with this 
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chronic disease population. In addition, the specific cardiovascular focused tools utilzed will 
clearly aid in the explanantion of the patient profile and illness contextual factor differences 
between the subject groups. Significant comprehensive compliance patterns that influence 
outcomes may also be evidenced by the usage of “The Patient-by-Treatment Context Interaction 
in Chronic Disease model.” Most research studies have focused on specific physiological 
outcomes as indicators of CR program success. The “Patient-by-Treatment Context Interaction in 
Chronic Disease Model,” is a comprehensive approach to evaluate this problem. Finally, the 
most important for the use of the conceptual model is significant interactions involving the 
T2DM+CAD and CAD groups may lead to the development of future adherence intervention 
strategies (and therefore improved outcomes) specifically for the T2DM+CAD population. 
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Figure 2.  Christensen’s Model Adapted to the Proposed Study Specific Aims. 
37 
1.4 SIGNIFICANCE OF RESEARCH STUDY FOR NURSING 
To date, no nursing research study has specifically examined the reasons why cardiac rehabilitation 
program appointment adherence is poorer for T2DM+CAD patients or why T2DM+CAD patients 
who complete cardiac rehabilitation programs have poorer adherence and functional outcomes 
utilizing Christensen’s “Patient-by-Treatment Context in Interaction in Chronic Disease Model”. 
Understanding the multifactorial key components of the Christiansen model and how these 
components interact permitted this candidate to develop as an independent researcher. Moreover, by 
utilizing this novel theoretical approach, the data collected and findings revealed some clinically 
meaningful trends  that are worthy of future investigation to inform CR care. 
 
1.5 PRELIMINARY WORK 
In preliminary preparation for this study, this candidate extensively reviewed both the coronary 
artery bypass graft procedure and cardiac rehabilitation enrollment statistics from Jefferson 
Regional Medical Center (JRMC) in order to ascertain the appropriate sample population size and 
demographic characteristics necessary to pursue this area of research. This work on the 2009 JRMC 
CR program statistics indicated that an average of 18 patients post primary isolated coronary artery 
bypass surgery were enrolled in their CR program each month. Importantly, sixty-five percent of all 
enrolled patients had a T2DM diagnosis. Estimating that 55% of eligible patient would be recruited 
with an attrition rate of 10%, recruitment of 44 subjects for this pilot study was determined as 
achievable within 7 months. 
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Furthermore, the abstract for research project, “Diabetic Coronary Heart Patients' 
Adherence to Cardiac Rehabilitation Programs” was accepted as a poster presentation for the 
Eastern Nursing Research Society’s 21’st annual scientific meeting. The review of literature article, 
“Factors Influencing the Outcomes of Patients with Both Coronary Artery Disease and Diabetes 
Enrolled in Standard Cardiac Rehabilitation Programs” was published in the Journal of 
Cardiovascular Nursing. 
To gain additional preparation to function as an independent investigator, the candidate 
served as a graduate student researcher on the National Heart, Lung, and Blood Institute‘s Grant 
R01HL074316, “Myocardial Ischemia and Vasospasm in Aneurysmal SAH”.  In this capacity, 
the candidate participated in subject recruitment, database management, data collection, data 
screening, statistical analysis and interpretation functions. These activities resulted in the submission 
of the manuscript entitled, “Relationship between Elevated Cardiac Troponin I and Functional 
Recovery and Disability in Patients after Aneurysmal Subarachnoid Hemorrhage” being 
accepted for publication by the American Journal of Critical Care.  In addition, the abstract for 
this specific research activity was accepted as a poster presentation at the 2009 National 
Teaching Institute and Critical Care Exposition.  
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2.0  RESEARCH DESIGN AND METHODS 
2.1 STUDY DESIGN 
This pilot study utilized a prospective descriptive comparative design to deign to explore if 
differences exist in the patient profiles and illness contextual factors between T2DM+CAD and 
CAD patients upon standard CR program entry after CABG, and if differences exist between 
groups in CR adherence and outcomes at CR program conclusion.  
 
2.1.1 The Patient-by-Treatment Context Interaction in Disease Model 
The causes for lower CR adherence and poorer outcomes for T2DM +CAD patients have not been 
fully explored. The “Patient-by-Treatment Context Interaction in Chronic Disease Model” 
developed by Dr. Alan Christensen provides direction for understanding how the multiplicity of 
individual disease perceptions and intrapersonal factors interact to impact treatment adherence and 
in turn treatment outcomes. As stated in Section 1.3, the primary assumption of Christensen’s 
behavioral-based model is that by analyzing specific patient profiles factors (sociodemographics, 
personality traits, locus of control, coping strategies, social support, and exercise treatment efficacy) 
in relationship to relevant illness contextual factors (disease stage, illness severity level, treatment 
regimen complexity, and co-morbidities)  individualized interventions can be designed to improve 
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treatment adherence rates, and therefore treatment outcomes. This pilot study design was based 
upon Christensen’s model with some adaptation to accommodate the pilot study population as 
Christensen recommends (Christensen, 2000). 
2.2 STUDY POPULATION 
2.2.1  Setting and Recruitment 
A convenience sample of subjects who enrolled in the standard Jefferson Regional Medical 
Center’s (JRMC) Phase 2 CR program following their CABG surgery between 12/16/2009 and 
07/26/2010 were recruited. JRMC is a 376-bed hospital located in the South Hills of Pittsburgh. 
Their CR program is supervised by a cardiologist, and consists of cardiac-monitored exercise 
sessions with exercise physiologists, nutritional counseling with a dietician, behavioral 
assessments with a psychologist, and risk factor modification classes administered by nurses. 
Subjects were recruited through referrals from JRMC’s Heart Institute physicians, nurses and 
therapy staff members. No "cold calling" occurred. Patients who met inclusion criteria (Section 
2.2.2) were asked by the Heart Institute staff for their permission to be contacted by the study’s 
Principal Investigator (PI).  Specifically, JRMC staff members discussed the research project 
with potential eligible patients and inquired if he/she expressed an interest in study participation. 
The patient signed a study approval form that (1) communicated with the PI that he/she was 
interested in study participation, (2) communicated with the PI the health information related to 
eligibility for inclusion into the study, and (3) allowed the PI to contact the patient for additional 
discussions related to the study. The PI asked the patient to sign a HIPAA-compliant consent 
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document for the study before a patient interview or medical record review of the patients chart 
for inclusion/exclusion criteria was conducted. The PI reviewed the study and all study 
procedures, risks and benefits with the patient prior to requesting signature for written informed 
consent to act as a subject in a research study. Questions were encouraged and assurances given 
that if they did wish to participate in the study, their medical and nursing care would not be 
affected. The patient’s was informed that confidentiality of all information obtained would be 
maintained.   
All subjects were followed from CR program entry to conclusion (8 weeks), and 
managed according to local practice guidelines based on national standards and guidelines set by 
the American Academy of Sports Medicine. The study was approved by both by the Institutional 
Review Board at the University and the Quality Improvement Research Committee at JRMC. 
 
2.2.2 Subject Inclusion and Exclusion Criteria 
Subjects of both genders were included if they had undergone a primary (first time) isolated (no 
other concomitant surgery) CABG procedure. Because patients undergoing repeat 
revascularization by definition have more functional impairment, the sample was limited to those 
undergoing their first or primary CABG to limit confounding. Because valvular heart disease 
imposes functional impairment different from CAD, only patients undergoing CABG alone, 
known as isolated CABG, were enrolled. Therefore, the sample consisted of patients who had 
undergoing primary isolated CABG to limit the chance that between group differences, if found, 
were related to factors other than T2DM+CAD vs. CAD. In addition, subjects were age >40 
years, and had just been enrolled in the CR program. Exclusion criteria were age <40 years, had 
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undergone post-revised CABG or CABG combination surgery (i.e. CABG+Valve) or were not 
medically cleared for participation in the CR program. 
 
2.3 STUDY INSTRUMENTS 
A key component to the successful application of the “Patient-by-Treatment Context Interaction 
in Chronic Disease Model” is that all measurement devices should be defined in terms of the 
population being studied (Christensen, 1997; Christensen, 2000).  Study instruments were 
therefore selected for their applicability to the CAD population. These study instruments, along 
with the collection schedule and their reported Cronbach's alpha as an indicator of instrument 
internal consistency are listed in Table 1. 
2.3.1 Data Collection Times 
The Principle Investigator (PI) was the sole data collector. The two time points for data collection 
were at CR program entry (baseline), and at the 8 week (conclusion) CR evaluation. Baseline 
data were collected within 1-7 days following the patient’s first CR evaluation session, and the 
CR conclusion data were collected within 7 days of the last appointment in the 8-week session.  
The PI was the sole data collector for this proposed pilot study. 
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2.3.2 Data Collection Management 
 
 Data collection was held in a private room at Jefferson Regional Medical Center’s Cardiac 
Rehabilitation center at their first and last scheduled appointments. At both study points, the PI 
administered all study questionnaires, and performed all point-of-care testing. The time for the 
baseline assessment was 1 hour and the final assessment was 30 minutes. After initial information 
was obtained, the PI determined if the subject’s status with respect to group membership was 
allocated to the T2DM+CAD or CAD group.   
De-identified code numbers were assigned to each subject to maintain confidentiality.  A 
listing of these de-identified code numbers to patient names were kept in an encrypted external 
pass protected word file. All data was hand entered in a specially designed database. Hard copy 
data forms and security USB drive holding the Data Transfer Files were kept by the PI in locked 
file cabinets in a locked office.  All data collection forms will be filed in a double locked 
cabinet/office area in the University of Pittsburgh School of Nursing for a period of 5 years.
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Table 1. Study Variables, Tools, and Collection Schedule. 
Variables and Tools Collection Schedule Reported Cronbach’s 
alpha Program 
Entry 
Program 
Exit 
T2DM Disease Stage: 
1. Diabetes  HbA1c 
 
X 
 
X 
 
Patient Profile Factors: 
1. Standard Demographic Tool  
2. Personality Traits (Neo Five Factor Inventory) 
3. Locus of Control (Multi Locus of Control) 
4. Coping Strategies (Brief Cope) 
5. Social Support (Internal Support Evaluation List) 
6. Perceived Treatment Efficacy (PTE) 
 
X 
X 
X 
X 
X 
X 
  
 
.89 - .95 
.70 -  .93 
.50 - .90 
.77 - .86 
.95 
Illness Contextual Factors: 
CAD Disease Stage:  
1. Ejection Fraction 
2. Number of CABG vessels 
Illness Severity Level: 
1. NYHFC 
2. CCASG 
3.  Blood Pressure 
4.  Body Composition 
Treatment Regimen Complexity: 
1. Medication-Taking Pattern  
2. Medication-Taking Questionnaire 
Co-morbidities:    
1.  Co-morbidity Form 
 
X 
X 
 
X 
X 
X 
X 
 
 
X 
X 
 
X 
 
 
 
 
 
 
 
X 
X 
 
 
X 
 
 
 
 
 
 
 
 
 
 
.61-.75 
.61-.75 
Program Adherence: 
1. C-Rehab Appointment Attendance Record 
2. Morisky Medication-Taking Questionnaire 
Program Outcomes: 
1. % Change Functional Status (Jette Functional Status Index) 
2. % Change in Illness Severity Markers  
 
X 
X 
 
X 
X 
 
X 
X 
 
X 
X 
 
 
.61-.75 
 
.65-.81 
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2.3.3 Group Designation 
All patients were defined as having CAD by virtue of undergoing a CABG procedure, a criteria 
for admission to the rehabilitation program. The two study cohorts were further defined as 
follows:   
 The T2DM+CAD Group: CAD patients were defined as 
having T2DM if they had a history of DM, were being currently 
treated with insulin or an oral glycemic agent, or had a HbA1c 
>6.4% without treatment with insulin or an oral glycemic agent. 
HbA1C was determined by a fingerstick blood sample obtained by 
the PI at rehabilitation program onset and analyzed by a point-of-
care portable device (Metrika™; Sunnyvale, CA). 
The CAD Group: CAD patients reported no clinical history 
of DM, no treatment with insulin or an oral glycemic agent, and a 
HbA1c <6.4% without insulin or oral glycemic agents. 
 
2.3.4 Patient Profiles 
The components of patient profiles were measured by a variety of standardized questionnaires to 
assess sociodemographics, personality traits, locus of control, coping strategies, social support, and 
exercise treatment efficacy. Each of the patient profile tools yielded multi-item total and subscale 
scores. The questionnaires were all administered by the PI. 
 2.3.4.1 Sociodemgraphic Questionnaire 
 
A standard 24-item Sociodemographic questionnaire designed by the University of Pittsburgh’s 
School of Nursing was administered to all subjects. This questionnaire inquired about gender, 
age, race, primary language, income, home location, marital status, job classification, insurance 
type, religion, and education.  
2.3.4.2 Personality Traits: NEO Five Factor Inventory 
 
To understand the relationship between personality traits and health, the NEO Five Factor 
Inventory tool was utilized, which evaluates the five personality types of neuroticism, 
extraversion, openness, agreeableness, and conscientiousness (Costa, 1990). Higher scores on the 
NEO Five Factor Inventory indicate a greater degree of that characteristic in the subject (Costa, 
1990). Cronbach's alpha for this tool range from .89 to .95 and the test-retest reliability has 
ranged from 0.63 to 0.81(Costa, 1990). 
2.3.4.3 Locus of Control: Multidimensional Health Locus of Control   
 
The locus of control was measured by the Multidimensional Health Locus of Control instrument 
(MHLC Form C). This questionnaire was designed to elicit beliefs about an individual’s control 
over their health status (Wallston, 1994). Three areas of control are measured by this tool--
internal control, chance, and powerful others. The score on each subscale is the sum of the values 
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circled for each item on the subscale (i.e., where 1 = "strongly disagree" and 6 = "strongly 
agree") (Wallston, 1994).  A higher score on the MHLC indicates the subject has a perceived 
higher degree of the corresponding area of control. According to the developer of this 
instrument, a person with an “internal locus of control” orientation believes that health outcomes 
are controlled by some action in which he himself engages, while a belief that health outcomes 
are controlled only by fate or luck is “chance”, and finally that “powerful-others” is the belief 
that other people with power control important health outcomes Cronbach's alphas for this tool 
range from 0.70 to 0.93 (Wallston, 1994).   
2.3.4.4 Coping Strategies: Brief Cope Scale 
 
Coping Styles were measured by the Brief Cope Scale, a questionnaire designed to analyze 
individual problem solving and emotional coping behaviors in specific areas (Carver, 1990). It 
contains 28 items and is rated by the four-point scale, ranging from “I haven’t been doing this at 
all” (score one) to “I have been doing this a lot” (score four); thus higher scores represent greater 
coping strategies used by the respondents. The specific coping strategy subscales are “self- 
distraction” or the act of pursuing other activities away from reality such as daydreaming. Taking 
proactive actions to remove or circumvent stressors is an example of an “active coping 
behavior”. An attempt to reject the reality of the stressful event is the definition of “denial”. 
Turning to the use of alcohol or other drugs is a way of disengaging from the stressor and is 
defined as “substance use”. Getting sympathy determines “emotional support”. Giving up, or the 
act of withdrawing efforts is defined as “behavioral disengagement”. “Venting” is showing an 
increased need to discharge specific feelings. “Positive Reframing” is thinking about alternate 
ways to confront a particular stressor. “Planning” is organizing one’s thoughts on how to 
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confront stressors. “Humor coping strategies” entail making jokes about a certain stressor. 
“Acceptance coping strategies” can be defined as accepting that a stressful event has occurred 
and is real. Finally, “religious coping strategies” involve the increased need to participate in 
religious activities to decrease the stressor. Cronbach’s alphas for this tool have been measured 
at a low of .50 to a high of .90 (Carver, 1990).  
2.3.4.5 Social Support: Interpersonal Support Evaluation List 
 
The Interpersonal Support Evaluation List (ISEL) was used to evaluate emotional, instrumental 
and informational social support received by each of the subjects (Cohen, 1993). The perceived 
ability of having someone with whom to talk over problems denotes the “Appraisal” subset of 
the ISEL. “Social tangibility” measures an individual’s perceived ability of asking for and 
accepting material aid such as help with money, transportation or housekeeping issues . “Self-
esteem” measures an individual’s perceived worth. “Belonging” is the perceived ability of 
having someone to do things with, such as attending a CR program. Test-retest reliability 
(Pearson’s) for the ISEL tool has ranged from .77 to .86 and the internal alpha estimates range 
from .88 to .90 (Cohen, 1993). 
2.3.4.6 Exercise Efficacy: Therapeutic Self-Efficacy for Exercise Scale 
 
The Self-Efficacy for Exercise Scale, a 9-item questionnaire, was administered to evaluate 
exercise treatment perceptions and patient management (Wu, 2008). This scale measures a 
person's subjective estimation that he or she will be capable of engaging in a CR exercise 
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program three times a week. Higher values on the scale are indicative of subjects estimating they 
will be able to participate fully in exercise programs.  (Wu, 2008). 
 
 
 
2.3.5 Illness Contextual Factors 
The components making up the Illness Contextual Factors were based on 1) CAD disease stage,  
2)  illness severity levels, 3) treatment regimen complexity, and 4) co-morbidities. Each of these 
components was measured by a variety of standard tools in combination with a comprehensive 
review of the subject’s inpatient hospital medical and outpatient rehabilitation records.  
2.3.5.1 Coronary Artery Disease Stage 
 
Coronary artery disease stage was determined by reviewing the subject’s medical record for his 
or her left ventricular ejection fraction (LVEF) percentage score (normal >50%, borderline 35-
49%, abnormal <35%) (Curtis, 2003). Additionally, a comprehensive review of the subject’s CR 
program record provided information on the number of vessel bypasses performed during their 
CABG procedure.  
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2.3.5.2 Illness Severity Levels 
 
Illness Severity Levels was measured by first conducting a baseline New York Heart Association 
Functional Capacity Classification (NYHFC). This 4-item ordinal scale classified the extent of 
heart failure by placing patients in one of four categories; no symptoms, mild symptoms, marked 
limitation or severe limitations (Hurst, 2006). Moreover, the Canadian Cardiovascular Society 
Grading of Angina (CCSG) severity of illness scale was also completed. This scale 4-item scale 
(class 1, class 2, class 3, class 4) assessed illness severity according to the degree of physical 
limitations imposed by cardiac angina (Canadian Cardiovascular Society, 1976). Also, physical 
assessment information provided an indication of illness severity. Baseline blood pressure (BP) 
was assessed with a mercury sphygmomanometer and stethoscope with the patient in a sitting 
position after resting for 10 minutes. The Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure indicates that a BP of 
greater than 140/90 mmHg is indicative of Stage 1 hypertension (U.S. Department of Health and 
Human Services, 2009). Total body composition analysis consisted of measuring height, weight, 
and hip and waist circumference to determine body mass index (BMI) and waist-to-hip ratio 
(WHR). Height was measured with a standard height measuring tape. Subjects (in lightweight 
clothing and bare feet) were asked to step on a Tanita™ scale (Tokyo, Japan) to measure weight. 
BMI was then calculated by dividing weight in kilograms by height in meters, and BMI was then 
categorized as <24.9 not overweight, 25 to 29.9 overweight, and ≥30 as obese (Bays, 2007). 
Waist and hip circumferences were measured with a non-stretchable standard girth tape. For 
waist circumference (subject standing with arms at side, feet together, abdomen relaxed), the 
horizontal waist measurement was taken at the narrowest part of the torso between the umbilicus 
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and xiphoid process (American College of Sports Medicine, 2006). The horizontal hip 
circumference measure was taken at the maximal circumference of the hips/buttocks, just above 
the gluteal fold, and the Waist-to-Hip Ratio (WHR) then calculated by dividing the waist 
measurement by the hip measurement (American College of Sports Medicine, 2006). A WHR 
greater than 0.96 indicates that individuals are at greater risk for having serious cardiometabolic-
related health problems such as dyslipidemia, hypertension, atherogenesis and obesity (American 
College of Sports Medicine, 2006). 
2.3.5.3 Treatment Regimen Complexity 
 
Treatment Regimen Complexity was determined by each subject answering the PI’s  questions 
on their medication taking pattern. The question asked determines reported medication adherence 
habits based on patterns of forgetfulness, carelessness, and attitudinal influences. In addition, the 
Morisky Medication Taking Questionnaire, a 4-item questionnaire was administered to measure 
their self-reported medication taking behaviors at CR baseline and conclusion. Scores on the 
Morisky closer to 1 indicated better levels of compliance with medication administration. The 
reliability of these tools is reflected in their 0.61 and 0.75 measures of internal consistency 
(Morisky,1986). 
2.3.5.4 Comorbidities 
 
Comorbidities were obtained from responses on the Brief Co-Morbidity Questionnaire This 90-
item questionnaire designed by the Center for Research in Chronic Disorders of the University of 
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Pittsburgh’s School of Nursing asked subjects about other acute or chronic disease processes 
with which that they have been diagnosed.  
 
2.3.6 CR Program Adherence and Outcomes 
2.3.6.1 CR Program Adherence 
 
CR Program Adherence was evaluated by the number of prescribed CR visits that the patient 
actually attended divided by the prescribed number of sessions scheduled. Medication adherence 
was measured by comparing the initial answers of the subject’s self-reported baseline Morisky 
Medication Taking Questionnaire results to their answers at CR program conclusion.  
2.3.6.2 CR Program Outcomes 
 
CR Program Outcomes were evaluated through changes in functional status and illness severity 
markers between the time of CR program entry and conclusion.  
2.3.6.3 Functional Status Outcomes 
 
For the outcome of functional status changes, the results of the Jette Functional Index Scale 
(JFIS) at CR baseline and conclusion were compared. Eighteen activities of daily living are self-
reported by the patient, and then grouped into 5 categories: mobility, personnel care, hand 
activities, home chores, and role activities (Jette, 1980). Overall JFIS scores in functional areas 
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of the need for functional assistance, pain involved, and functional difficulty were then 
calculated by summing individual scores of all 18 items and dividing by the total number of 
items (Jette, 1980). Higher scores indicate more self-reported functional difficulty in 
accomplishing specific tasks or more assistance required to accomplish these tasks. Test-retest 
and internal observer values range from 0.65 to 0.81 (Jette, 1980).  
2.3.6.4 Illness Severity Change Outcomes 
 
For the outcome of illness severity changes, the comparisons of the baseline and CR program 
conclusion measurements of HbA1c, BP, BMI and WHR between the cohorts were compared, 
and the percentage of change within the cohort over time determined.  
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3.0  DATA MANAGEMENT AND STATISTICAL ANALYSES  
3.1 DATA ANALYSIS FOR SPECIFIC AIMS 1, 2 & 3  
Data were key-entered directly into the database by the PI and verified by an independent 
reviewer. PASW (Version 18.0, IBM, Inc., Chicago, IL, USA) was used for data analysis. Data 
screening performed prior to analyses included checking for accuracy input, outliers, amount and 
pattern of missing data, multicollinearity and violations in statistical assumptions (e.g., 
normality, homoscedasticity). 
Group-specific statistics were computed considering each variable’s level of 
measurement and data distribution for personality profile factors (Aim #1), illness contextual 
factors (Aim #2), and pre- to post-CR changes in program adherence and outcome variables 
(Aim #3). Normality assessment indicated that continuous type data were non-normally 
distributed. Thus, nonparametric methods were utilized to describe and compare study cohorts. 
Categorical descriptors were summarized using group-specific frequencies and percentages and 
contingency table analyses with chi-square tests of independence (or Fisher exact tests, if sparse 
cells) were employed to compare proportions between groups. Continuous type variables were 
described using group-specific medians and inter-quartile ranges and compared using the Mann-
Whitney U-test between the study cohorts. Exact estimation of p-values was employed. Effect 
sizes (odds ratios [OR] for categorical factors and Cohen’s D calculated as the standardized 
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mean differences based on ranked data) with 95% confidence intervals were computed to 
summarize the differences between study groups. The following social science guidelines for 
determining effect sizes were utilized; negligible effect r < 0.049, small effect size r 
= 0.05 − 0.349, medium effect size r = 0.35 − 0.55, large effect size r = ≥ 0.56. (Cohen, 1988) 
 
3.2 DATA ANALYSIS FOR SPECIFIC AIM 4 
The statistical plan was to perform bivariate correlations and simple linear regression between 
Illness Contextual factors, Patient Profile factors, and program adherence and outcome variables 
if the univariate analysis demonstrated significance of relationships warranting further 
exploration. Next, multiple regression analyses was to be conducted to explore the main effects 
and two-way and three-way interaction effects of Illness Contextual factors, Patient Profile 
factors, and diabetes status on program adherence and outcome variables. In addition, effect sizes 
(regression coefficient with 95% confidence intervals) were to be estimated for each main effect 
and interaction effect. R-square statistics would be calculated to summarize the percentage of 
variance explained in the program adherence and outcome variables. Finally, residual analyses 
were to be performed to identify instances of model misspecification and influential 
observations. 
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4.0  HUMAN SUBJECT RESEARCH 
4.1 RESPONSIBLE CONDUCT OF RESEARCH 
The University of Pittsburgh Education & Certification Program in Research & Practice 
Fundamentals is an on-line educational series designed to provide training to individuals at the 
University of Pittsburgh, and its affiliated institutions, who wish to participate in research 
activities. This program is required of all doctoral students and students serving as Graduate 
Student Researchers (GSR’s); the applicant functions in both roles. Several modules comprise 
the on-line training series and the modules required for doctoral students and GSR’s include: 
Module 1-Research Integrity, Module 2-Human Subjects Research, Module 6-HIPPA 
Researchers Privacy Requirements, and Module 14-UPMC HIPPA Staff Security Awareness 
Training. Certificates of the candidate’s successful completion of the modules are on file in the 
Student Affairs Office.  
           Moreover, ethical issues related to human subjects’ research are incorporated in 
the BSN-PhD curriculum in both the Master’s and Doctoral level courses including Nursing 
Theory and Research, Coordinating Clinical Trials, Research Methods, Qualitative Research, 
Pilot Study, Grant Writing Practicum and others. Areas covered in these courses include topics 
concerning the process of informed consent, participant confidentiality, conflict of interest, 
research integrity, protection of vulnerable subjects, internal audit procedures, seeking IRB 
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approval, adverse event monitoring as well as many more. Further instruction was also received 
through the various research seminars the applicant will attend including Survival Skills 
Workshop, Research Methodology Series and Research Progress Update Series available 
throughout the University. Additionally, having worked as a Graduate Student Researcher, the 
candidate has had first-hand experience of the detailed elements related to the responsible 
conduct of research- ensuring ID numbers are always separate from participant names, locking 
the secure computer database, maintaining privacy during the collection of bloodwork and 
cerebral spinal fluid. Working on a large study has proved to be an invaluable experience that  
introduced the applicant to the many of the aspects of conducting sound, ethical research.  
4.2 INFORMED CONSENT AND THE IRB 
Following a description of the research purpose and protocol including procedures, risks and 
benefits as presented by the PI, patients were asked to provide informed consent. Only patients 
providing informed consent were allowed to proceed to the data collection interview. Subjects were 
allowed to withdraw from the study at any time. Both the Institutional Review Boards at the 
University of Pittsburgh and Jefferson Regional Medical Center approved the study protocol prior 
to study initiation. The IRB approval form can be found in Appendix B and the JRMC approval 
letter is found in Appendix C. 
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4.3 PROTECTION OF HUMAN SUBJECTS 
This study involved minimal risk. The PI performed all study procedures. There were no known 
risks with the measurement of height, weight, waist circumference, and BP. No patients being 
interviewed regarding personal demographics, medical history, or answering the questionnaires, 
reported having any discomfort regarding their social situation or recall of unpleasant experiences. 
In addition, the risks of blood sampling by fingerstick were minor, occurring in < 25% (< 25 out of 
100 people) and this did not occur in the research study (Garon, 2004). 
To minimize these risks, only the trained PI obtained fingerstick blood samples. There was 
some risk that a patient might become upset if a previously undiscovered condition of 
hyperlipidemia, hypercholesterolemia, or diabetes was discovered because of blood test results. This 
did not occur. There could be a risk to patient privacy if confidentiality of the research records was 
breached. All records were kept in a locked cabinet within the PI's locked office and this offense did 
not occur.  
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4.4 WOMEN, MINORITY AND CHILDREN INCLUSION IN RESEARCH 
The study was based on the sample population demographics of JRMC. No potential participants 
will be excluded from the study based upon gender. 
In terms of minorities, the proposed study was based on the demographics of JRMC and 
included 98% Caucasians and 2% African Americans admitted for primary isolated vessel 
CABG surgery. No potential participants will be excluded from the study based upon race or 
ethnicity.  
Children were not included in this proposed research since: a) the prevalence of 
significant coronary artery disease requiring CABG in individuals < 21 years of age is almost 
non-existent, and b) the clinical site restricts admissions to adults. 
 
4.5 DATA SAFETY AND MONITORING PLAN 
Since this pilot study involved minimal interventional risk to subjects and is not a multi-site 
clinical trial, a formalized Data Safety and Monitoring Plan was not warranted for this study. 
However, with respect to participant safety and electronic data integrity, the PI reviewed 
monthly all data collection processes including point of care testing to assess that procedures 
were conducted according to standard research protocols. Furthermore, the PI issued a report to 
the Dissertation Chair regarding the findings of these monthly reviews. 
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5.0  RESEARCH RESULTS AND DISCUSSION: SPECIFIC AIMS 1-3 
A convenience sample of 51 subjects was recruited. Two subjects requested to be withdrawn 
from the study and one subject chose to attend a different CR program center closer to his home 
after completing their initial CR program evaluation, leaving a final sample size of 48 (26 CAD 
and 22 T2DM+CAD subjects).  
5.1 PATIENT PROFILE RESULTS 
5.1.1 Patient Sociodemographic Results.  
As displayed in Table 2, there were no statistically significant differences in sociodemographics 
between the CAD and T2DM+CAD cohorts, although the following trends were noted. The 
T2DM+CAD cohort has a smaller proportion of males (50%) than the CAD cohort (73%). The 
T2DM+CAD cohort tended to have a slightly higher proportion of subjects younger than 64 
years (59%) than CAD (54%) subjects. Subjects in both cohorts were primarily white, English 
speaking, and married. More CAD subjects reported living in the city while more T2DM+CAD 
subjects reported living in a rural community setting. CAD subjects reported working or having 
worked in traditional management positions such as plant managers or productivity directors. 
Subjects with T2DM+CAD reported holding or having held labor positions such as steelworkers, 
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mechanics or secretaries. A higher proportion of the CAD cohort (62%) were still currently 
employed as compared to the T2DM+CAD cohort (46%). The majority of subjects in both 
cohorts reported gross income levels of more than $50,000 per year, and the majority of both 
cohorts held commercial health insurance plans. Eighty-five percent of subjects in both cohorts 
indicated that religion played an important role in their healthcare decisions.  
5.1.2 Pre Rehabilitation Program Clinical Characteristics Results 
As expected, the T2DM+CAD cohort demonstrated significantly higher HbA1c values than the 
CAD cohort (Tables 3 and 6) since HbA1c was a cohort-defining variable (p<0.001). 
Nevertheless, a little over 40% of the CAD cohort who did not have a prior T2DM history or 
intervention presented with a HbA1c level in the range of 5.7mg/dl to 6.4mg/dl, consistent with 
the definition of a prediabetic state. There were no statistically significant differences in the other 
clinical characteristics at baseline between the cohorts, but again trends were noted. About 54% 
of the T2DM+CAD cohort exhibited abnormally low LVEF compared to only abnormally low 
LVEF in only 8% of the CAD cohort. The CAD population tended to be more likely to have 5 or 
more vessels bypassed than T2DM+CAD subjects (39% vs. 23% respectively).  
Only 19% of the CAD cohort and 9% of the T2DM+CAD cohort were of normal weight. 
Although not statistically significant, slightly more CAD subjects (54%) tended to have a BMI 
≥30 as compared to T2DM subjects (46%), and the T2DM+CAD subjects tended to have a WHR 
in the high-risk range (36%) as compared to the CAD subjects (23%). 
Even though at baseline the majority of both cohorts had systolic and diastolic BPs within 
the normal range, the systolic values for the T2DM+CAD group was slightly, although non-
significantly, higher than the CAD group. The majority of both cohorts were placed in either 
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Class 1 or Class 2 of the NYHFC scale and the CCSG scale. There was a trend towards 12 or 
more co-morbidities being reported by the T2DM+CAD cohort (32%) than the CAD cohort 
(15%). Nevertheless, there were no significant between group differences in baseline self-reports 
for medication adherence, nor in functional abilities as measured by the Jette scale related to 
need for functional assistance, pain involved, or functional difficulty in performing tasks.  
 
5.1.3 Patient Profiles Characteristics Results 
Patient profile characteristic comparisons (Table 4) revealed no statistically significant 
differences between the cohorts. However, several of the between-cohort comparison effect sizes 
indicated a small to medium effect size, especially in the analyses of personality traits. The NEO 
Five Factor Inventory tool indicated that the CAD cohort tended to be more agreeable and 
conscientiousness, whereas the T2DM+CAD cohort tended to be more neurotic, extraverted and 
open. Although there were no statistically significant differences noted in locus of control 
between the cohorts, the CAD cohort tended to believe that chance controlled health outcomes, 
whereas the T2DM+CAD cohort tended to believe that internal control and powerful others was 
more important, as suggested by the small to medium effect sizes on these traits.  
The Brief Cope assessment revealed that the T2DM+CAD cohort trended towards a 
greater likelihood to exhibit coping behaviors of active coping, emotional support, positive 
reframing (small effect size) and venting (medium effect size). The CAD cohort had a slightly 
higher tendency to use religious and acceptance coping styles (small effect size) more frequently 
than the T2DM cohort. However, none of the between-cohort comparisons were statistically 
significant.  
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On the Interpersonal Support Evaluation List, the cohorts were equal in the subscales of 
appraisal, tangible, and belonging categories while the CAD cohort trended towards higher self-
esteem. Although there were no statistically significant differences between the cohorts on the 
Self-Efficacy for Exercise Scale, the CAD cohort thought of themselves as more likely to be able 
to participate fully an exercise program than the T2DM+CAD cohort, as suggested by the 
medium effect size. 
5.2 ILLNESS SEVERITY MARKERS  
As noted in Tables 5 and 6, the T2DM+CAD cohort achieved small improvement in their HbA1c 
levels between baseline and conclusion of CR program. The CAD cohort actually increased their 
HbA1c levels over time. The HbA1c percent of change from baseline over time (4% 
improvement for T2DM+CAD and 5% worsening in CAD) was statistically significant 
(p=0.045). Otherwise, there were only minimal changes with small effect sizes in the other 
variables. 
5.3 PROGRAM ADHERENCE AND OUTCOMES 
5.3.1 Program Appointment and Medication Adherence 
Both groups showed equality in program attendance, with about 80% of CR program 
appointments kept for both groups, and there were no significant between-cohort differences. No 
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differences in CR program adherence were noted. Both cohorts self-reported some medication 
non-adherence, with a tendency towards greater non-adherence for the T2DM+CAD cohort, and 
neither cohort improved from their baseline medication adherence by CR program conclusion.  
5.3.2 Functional Status Results 
No significant changes were demonstrated in the analyses of functional abilities between the 
cohorts, or within each cohort over time. However, several trends were noted. The CAD cohort 
demonstrated less need for functional assistance that the T2DM+CAD cohort at baseline. The 
T2DM+CAD cohort still needed more assistance at program conclusion, even though both 
cohorts improved slightly.  
5.4 DISCUSSION 
The results of this pilot study indicated that although few statistically significant differences 
between the cohorts were found, a number of trends that are clinically meaningful were revealed. 
Although our CAD and T2DM+CAD cohorts were statistically similar on sociodemographics, 
we did note some trends in gender and age. Our overall sample was about 2/3 male as has been 
typically reported in CR program literature (Mourot, 2010; Suresh, 2000), but our gender 
dispersion was 73% males in the CAD cohort and only 50% males in the T2DM+CAD cohort. 
This relatively greater tendency toward female gender in the cohort with diabetes might be 
related to the greater disease burden of T2DM in females. The literature indicates that although 
the prevalence of T2DM is only slightly higher in women as compared to men, the 
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cardiometabolic complications of diabetes has a significantly greater impact on women (Cowie, 
1995; Wishner, 1996). Women diagnosed with T2DM also have as much as a 22-42% greater 
degree of functional disabilities due to diabetic complications like peripheral neuropathy or 
diabetic retinopathy. Although currently CR programs admit more men than women following 
revascularization (Deshotels, 1995; Sanderson, 2010; Mayo Clinic, 2010), the anticipated rise in 
T2DM+CAD prevalence in the future may in turn result in increased revascularization needs in 
women. If so, CR programs may need to be prepared to admit more women in the future. Such 
an eventuality might impact the approaches that CR programs take to exercise, diet and behavior 
modification (Gregg, 2000; Gregg 2002). Another interesting finding was that our T2DM+CAD 
subjects participating in CR tended to be of a slightly younger age than the CAD cohort. 
Although CAD alone is more prevalent in adults 65 years or older, T2DM risk increases at age 
45 years, and heart disease death rates are about 2 to 4 times higher than in adults without DM 
(NIDDK, 2011). If our trend towards T2DM+CAD patients in CR programs being younger is 
supported by further study, then perhaps CR program approaches might require age-based 
readjustments.  
We did not find any statistically significant differences between our cohorts on the other 
aspects of patient profiles, although again a few trends were noted. Our CAD cohort showed a 
tendency (medium effect size) towards higher conscientiousness. CAD patients have been linked 
in research to Type A behavior patterns (Suls, 1989), and are characterized by their competitive 
nature and desire to achieve (Suls, 1989). Although our T2DM+CAD patients tended to report 
lower self-efficacy for exercise (medium effect size), we also noted a tendency (medium effect 
size) for the T2DM+CAD cohort toward more adaptive coping strategies. Perhaps this tendency 
may be explained in part by having coped with a chronic disease state for a longer period of 
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time. Research has demonstrated that being able to manage a chronic disease with proactive self-
care behaviors effectively reduces the overall risk of developing complications (Bai, 2009). CR 
programs might encourage exercise self-efficacy and tap into the coping tendencies of 
T2DM+CAD patients to provide insight to managing their disease state, since there is evidence 
that hosting intense multifactorial cardio-metabolic classes to highly capable T2DM patients 
generates improved physiological outcomes. (Bai, 2009) 
In terms of Illness Contextual Factors at CR program entry, other studies have reported 
T2DM+CAD HbA1c levels in the range of 7.7 to 8.2 mg/dl (Suresh, 2001; Verges, 2004), while 
our T2DM+CAD cohort mean HbA1c at baseline was somewhat lower at 6.6 mg/dl. This may be 
partially due to a more recent emphasis on tighter glycemic control in DM patients than in the 
older comparative studies (ADA, 2010; Ford, 2008). However, a disturbing trend noted in our 
study is that 42% of the CAD cohort exhibited a HbA1c level in the range of pre-diabetes or 5.7-
6.4 mg/dl. If corroborated in a larger study, CR programs will need to be vigilant in that many 
patients who are not diagnosed with DM may still be borderline for its development, and that 
diet and other cardio-metabolic risk factor modification should be emphasized. 
Reinforcing the connection between cardio-metabolic risk factors and DM was the noted 
tendency that the T2DM+ CAD cohort had fewer vessels bypassed than the CAD cohort, while 
at the same time tending to have a lower baseline LVEF. These tendencies might be related to 
the increased likelihood of patients with DM to have a stronger microangiopathic component to 
their vascular disease process, rather than only large vessel lesions (Flaherty, 2005), as well as 
the propensity for DM patients to have a greater preponderance of diastolic dysfunction and 
myocardial fibrosis as the pathophysiologic underpinning to their heart failure (Brown, 2004; 
Paulsen, 2010). It might be helpful for CR programs to be aware that even though T2DM 
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patients have fewer vessels bypassed, they may still have remaining risk for myocardial 
perfusion abnormalities.  
CR programs represent a multi-component process of medical evaluation and prescribed 
exercise plans combined with educational and counseling sessions aimed at targeting traditional 
risk factors for CAD, with the goal of changing behavioral patterns of participants in order to 
produce improved physiological results (Beswick, 2005, Woodgate, 2008). Prior research has 
suggested that T2DM+CAD patients are more likely to drop out of CR programs than CAD 
patients. Both of our cohorts demonstrated an 80% mean appointment adherence rate (or on 
average 5 missed sessions out of the 24 scheduled over the 8 weeks). Other research has noted 
CR appointment attendance rates of 92% for CAD patients and 42-62% for T2DMD+CAD. Thus 
our CAD cohort had somewhat poorer attendance than reported by other studies, while our 
T2DM+CAD cohort was slightly better than others. Possibly, the lower rate of employment for 
our T2DM cohort as compared to CAD might have helped to foster their equivalence in 
appointment adherence. Our study interval was not long enough to determine if there was any 
seasonal variation in attendance which could have affected results. 
When examining our findings obtained at CR program conclusion, we noted that self-
reported medication adherence was less than perfect in both the CAD and T2DM+CAD cohorts, 
as evidenced by their Morisky scores of greater than zero, with slightly poorer adherence in the 
T2DM group, but both groups reported little improvement in medication adherence by CR 
program conclusion. This finding has implications for CR programs, since the literature suggests 
that practical support is associated with increased levels of adherence behaviors (Molloy, 2008), 
and such supportive measures might eventually improve a patient’s medication taking pattern.  
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At program conclusion, we also noted that the illness severity measures including HbA1c 
levels, BMI, WHR or BP levels demonstrated no change from baseline in either cohort. In fact, 
the mean HbA1c level of our CAD cohort was higher at program conclusion than at baseline. 
These findings suggest that the duration of the standard 8-week CR program is too short a time 
for behavior to change, or for behavior changes to result in demonstrable improvement of illness 
markers or cardiometabolic risk factors. Due to insurance and financial constraints, most CR 
subjects participate in only the short 8-week CR programs. A recent investigation reported that to 
change patients’ behaviors, it is recommended that CR programs include post-home care 
interventions to facilitate and reinforce CR learning (Arrigo, 2008). In terms of physical 
function, our preliminary study noted no significant functional improvements for either cohort in 
terms of need for functional assistance, pain involved, or functional difficulty in accomplishing 
tasks. However, our data indicated that although both groups demonstrated similar degrees of 
pain and difficulty in functioning, the T2DM+CAD cohort tended to need more assistance with 
function than the CAD cohort, at both baseline and program conclusion. Other studies have 
demonstrated that diabetics in CR programs are able to perform functions less well and have 
worse functional outcomes than individuals without diabetes. (Suresh, 2001; Verges, 2004). Our 
findings, although limited, corroborate this, and would lend some support to CR programs taking 
the special exercise limitations and needs of the diabetics into account, rather than applying a 
generic exercise program to all participants.  
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5.5 LIMITATIONS 
 
Our study had several limitations. First, because this was a pilot study, our sample size was small 
and underpowered to demonstrate statistically significant results. Nevertheless, the measures of 
effect size are useful in determining which components should undergo further study and that 
some relationships may have achieved significance with a larger sample. Also, our study was 
limited to examining patients at only a single center, and the trends noted may not be 
generalizable. Third, our measures of medication adherence and physical function were obtained 
from self-reports, and more objective measurement approaches might have yielded different 
results. Also we did not collect data on exercise complexity or escalation, which might have 
provided additional information on functional outcomes.  
 
5.6 CONCLUSION 
This pilot study suggests that although the patient profiles and illness contextual factors of 
patients undergoing CR programs after CABG revascularization are statistically similar between 
CAD and T2DM+CAD patients, there are some interesting trends that may be clinically 
meaningful and worthy of further study. These trends, if proven to be significant in a better 
powered study, may help to determine if CR programs need to take the specialized personality 
and illness characteristics of patients with T2DM+CAD into account. Although not an aim of our 
study, we also found that CAD patients who were not diagnosed with DM frequently exhibited 
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HbA1c levels in the range of a prediabetic state, and CR staff should be vigilant to this potential 
problem. Lastly, few changes or improvements were noted in disease severity or physical 
findings over the CR program interval, but the 8-week time frame is likely too short for such to 
occur.  
5.7 TABLES 2 TO 6
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Table 2. Socio-demographic characteristics for the total sample (N=48) and for subjects with coronary artery disease only 
Variables All Subjects 
(N = 48) 
CAD 
(n = 26) 
T2DM + CAD 
(n = 22) 
Test 
Statistic 
p-value  Odds Ratio 
(95% Confidence Interval) 
Gender n (%) 
Male 
 
30 (62.5%) 
 
19 (73.1%) 
 
11 (50%) 
X2(1)= 2.70  0.100 ‡ 2.714  
(0.814 - 9.047) 
Age n (%) 
>64 years 
<64 years 
 
21 (43.8%) 
27 (56.2%) 
 
12 (46.2%) 
14 (53.8%) 
 
9 (40.9%) 
13 (59.1%) 
X2(1)=0.13 0.715 ‡ 1.238 
(0.393-3.901) 
Race n (%) 
White  
African-American 
 
46 (95.8%) 
2 (4.2%) 
 
25 (96.2%) 
1 (3.8%) 
 
21 (95.5%) 
1 (4.5%) 
X2(1)=0.015 0.712 ‡ 1.191 
(0.070-20.212) 
English Primary Language n (%) 48 (100%) 26 (100%) 22 (100%)    
Gross Income n (%) 
>$50,000  
<$50,000  
refused to disclose 
 
25 (52.1%) 
16 (33.3%) 
7 (14.6%) 
 
13 (50.0%) 
8 (30.8%) 
5 (19.2%) 
 
12 (54.5%) 
8 (36.4%) 
2 (9.1%) 
FISHER 
EXACT 
N/A 
0.625 ‡ 1.083 
(0.309-3.802) 
Area n (%) 
Rural  
City 
 
24 (50.0%) 
24 (50.0%) 
 
10 (38.5%) 
16 (61.5%) 
 
14 (63.6%) 
8 (36.4%) 
X2(1)=3.02 0.082 ‡ 0.357 
(0.110-1.156) 
Marital status n (%)  
Married  
Single 
 
36 (75.0%) 
12 (25.0%) 
 
22 (84.6%) 
4 (15.4%) 
 
14(63.6%) 
8 (36.4%) 
X2(1)=2.79 0.094 ‡ 3.143 
(0.795-12.425) 
Job Class n (%) † n=46 
Management 
Labor 
n = 46 
20 (43.5%) 
26 (56.5%) 
n  = 26 
14 (53.8%) 
12 (46.2%) 
n = 20 
6 (30.0%) 
14 (70.0%) 
X2(1)=2.62  0.106 ‡ 2.513 
(0.743-8.498) 
Are you currently employed? n(%)        
Yes  
No 
 
26 (54.2 %) 
22 (45.8 %) 
 
16 (61.5 %) 
10 (38.5 %) 
 
10 (45.5 %) 
12 (54.5 %) 
X2(1)=1.24  0.650 ‡ 1.920 
(0.606-6.079) 
 
Insurance type n (%)  
Private  
Commercial 
 
18 (37.5%) 
30 (62.5%) 
 
9 (34.6%) 
17 (65.4%) 
 
9 (40.9%) 
13 (59.1%) 
X2(1)=0.20  0.654 ‡ 0.765 
(0.237-2.471) 
Religion n (%)  
Yes important  
 
41 (85.4%) 
 
22 (84.6%) 
 
19 (86.4%) 
X2(1)=0.23  0.864 ‡ 0.868 
(0.172-4.379) 
High School n (%)  
Yes 
 
45 (93.8%) 
 
25 (96.3%) 
 
20 (90.9%) 
X2(1)=1.23 0.546 ‡ 2.500 
(0.211-29.599) 
† All Subjects N=46, CAD n=26, T2DM+CAD n=20  ‡= reference from first to second category of CAD-T2DM for calculating odds ratio. 
Table 3. Pre-rehabilitation program clinical characteristics for the total sample (N=48) and for subjects with coronary artery disease only 
(CAD, n=26) and for subjects with type II diabetes plus coronary artery disease (T2DM+CAD, n=22). 
Variables All Subjects 
(N = 48) 
CAD 
(n = 26)
T2DM + CAD 
(n = 22) 
Test 
Statistic 
p-value Odds Ratio 
(95% Confidence Interval) 
Hemoglobin A1C  Range n (%)  
  Normal < 5.7 mg/dl ‡ 
  Pre-diabetes 5.71-6.4 mg/dl  
  Diabetes >6.5 mg/dl  
 
16 (33.3 %) 
17 (35.4 %) 
15 (31.3 %) 
 
15 (57.7%) 
11 (42.3%) 
0 (0.0%) 
 
1 (4.5%) 
6 (27.3%) 
15 (68.2%) 
X2(2)=28.59 
 
 
<0.001 
 
‡0.122 
(0.013-1.166) 
§Undefined 
(NA) 
Hemoglobin A1C n (%)  
Normal < 6.4 mg/dl ‡ 
                Diabetes >6.4 mg/dl 
 
33(68.8%) 
15(31.3%) 
 
26(100%) 
0(0%) 
 
7(31.8%) 
15(68.2%) 
X2(1)=25.8 
 
<0.001 
 
‡ Undefined 
(NA) 
†Ejection Fraction Range n (%)  
 Abnormal <35% ‡ 
  Borderline 36-49% 
  Normal >50 
 
5 (10.4%) 
11 (22.9%) 
31 (64.6%) 
 
2 (8.0%) 
4 (16%) 
19 (76%) 
 
12 (54.5%) 
7 (31.8%) 
3 (13.6%) 
X2(2)=2.41 0.299 ‡0..292 
(0.042-2.023) 
§0.026 
(0.004-0.181) 
†Ejection Fraction n (%)  
 Abnormal <50% ‡ 
                 Normal >50 
 
16(34%) 
31(66%) 
 
6(24%) 
19(76%) 
 
10(45.5%) 
12(54.5%) 
X2(1)=2.39 0.139 ‡ 0.471 
(0.132-1.680) 
Number of  Vessels Bypassed 
                <5 Vessels ‡ 
                >5 Vessels 
 
33(68.8%) 
15(31.2%) 
 
16(61.5%) 
10(38.5%) 
 
17(77.3%) 
5(22.7%) 
X2(1)=1.37 0.241 ‡ 2.125 
(0.595-7.830) 
Body Mass Index Range n (%)  
0-24.9 Normal ‡ 
25-29.9 Overweight 
> 30 Obese 
 
7 (14.3%) 
17 (34.7%) 
24 (50 %) 
 
5 (19.2%) 
7 (26.9 %) 
14 (53.8 %) 
 
2 (9.1%) 
10 (45.5%) 
10 (45.5%) 
X2(2)=1.55 0.487 
 
 
‡3.571 
(0.533-23.954) 
§1.785 
(0.287-11.128) 
Body Mass Index n (%)  
< 25 Normal ‡ 
> 25 Abnormal 
 
7(14.6%) 
41(85.4%) 
 
5(19.2%) 
21(80.8%) 
 
2(9.1%) 
20(90.9%) 
X2(1)=0.98 0.321 ‡ 2.381 
(0.414-13.708) 
Waist to Hip Radius Range n (%)                  
               Small risk < 0.96 
               High risk > 0.96 
 
34(70.8%) 
14(29.2%) 
 
20(76.9%) 
6(23.1%) 
 
14(63.6%) 
8(36.4%) 
X2(1)=1.01 0.313 ‡ 1.905 
(0.540-6.713) 
New York Heart Association class n (%)  
  Class 1 ‡ 
  Class 2 
  Class 3 
  Class 4 
 
23 (47.9%) 
19 (39.6%) 
5 (10.4%) 
1 (2.1%) 
 
14 (53.8%) 
9 (34.6%) 
3 (11.5%) 
0 (0%) 
 
9 (40.9%) 
10 (45.5%) 
2 (9.1%) 
1 (4.5%) 
X2(3)=2.03 0.568 ‡1.728 
(0.505-5.912) 
§1.037 
(0.144-7.478) 
 
Canadian Angina Classification n (%)            
  Class 1 ‡ 
  Class 2 
  Class 3 
 
27 (56.3%) 
17 (35.4%) 
4 (8.3%) 
 
16 (61.5%) 
8 (30.8%) 
2 (7.7%) 
 
11 (50.0%) 
9 (40.9%) 
2 (9.1%) 
X2(2)=0.65 0.720 ‡ 1.636 
(0.482-5.561) 
§1.455 
(0.172-11.937) 
Number Co-morbidities per Subject n (%) 
  < 11 Co-morbidities‡ 
   >12  Co-morbidities 
 
37(77.1%) 
11(22.9%) 
 
22(84.6%) 
4(15.4%) 
 
15(68.2%) 
7(31.8%) 
X2(1)=1.82 0.302 ‡ 2.567 
(0.638-10.334) 
† All Subjects N=47, CAD n=25, T2DM+CAD n=22;  ‡= reference from first to second category CAD-T2DM for calculating odds ratio. § = reference first to third category  
CAD-T2DM for calculating odds ratio. 
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 Table 4. Pre-rehabilitation program patient profile factors for the total sample and for subjects with coronary artery disease only (CAD, n=26) 
and for subjects with type II diabetes plus coronary artery disease (T2DM+CAD, n=22). 
Variables 
Median  (Interquartile Range) 
CAD 
(n =26) 
T2DM + CAD 
(n=22) 
Test  
Statistic 
 
p-value 
 
‡  Cohen’s d 
Effect Size 
Interpretation 
Neo Five Factor Inventory †     
Neuroticism  16.0 (10) 18.0 (15.0) U=344.5  0.126 d = -0.452 Medium 
Extraversion 26.5(8.0) 28.0 (17.0) U=283 0.830 d = -0.061 Small 
Openness 22.0 (9.0) 24.0 (11.0) U=356.5 0.073 d = -0.537 Medium 
Agreeableness 35.0 (4.0) 32.0 (12.0) U = 234 0.402 d =  0.240 Small 
Conscientiousness 37.0 (9.0) 32.0 (12.0) U=197 0.103 d =  0.485 Medium 
Multi -Dimensional  Health Locus of Control   
Internal 25.0 (11.3) 27.0 (9.0) U=344 0.229 d = -0.349 Small 
Chance  13.0 (12.5) 11.0 (6.0) U=208.5 0.108  d =  0.477 Medium 
Powerful Others  25.0 (4.0) 26.0 (7.0) U= 313.5 0.568 d = -0.162 Small 
Brief Cope     
Self –Distraction 4.0 (2.0) 4.0 (4.5) U = 310 0.614 d  = -0.144 Small 
Active Coping 6.0 (3.0) 7.0 (2.5) U = 327.5 0.378 d = -0.144 Small 
Denial 2.0 (1.0) 2.0 (0.0) U = 288 0.130 d =  0.000 Negligible 
Substance use 2.0 (0.0) 2.0 (0.0) U = 288 0.905 d = -0.034 Negligible 
Emotional Support 5.5 (3.0) 6.0 (2.5) U =305.5 0.682 d = -0.117 Small 
Behavioral 
Disengagement 
2.0 (0.0) 2.0 (0.0) U = 291 0.829  d = -0.061 Small 
Venting 2.5 (2.0) 4.0 (2.5) U = 359.5 0.107 d = -0.472 Medium 
Positive Reframing 4.5 (4.0) 6.0 (2.5) U = 330.5 0.350 d = -0.271 Small 
Planning 5.5 (3.0) 6.0 (2.0) U = 299 0.785 d = -0.078 Small 
Humor 3.0 (2.0) 3.0 (2.0) U = 306  0.663 d = -0.121 Small 
Acceptance 7.0 (2.0) 6.0 (3.0) U = 260 0.578 d =  0.158 Small 
Religion 5.5 (5.0) 5.0 (4.0) U = 258.5 0.564 d =   0.167 Small 
Interpersonal Support Evaluation List  
Appraisal 14.0 (2.0) 14.0 (3.5) U=260.5 0.590 d =  0.154 Small 
Tangible 15.0 (2.0) 15.0 (2.5) U=282 0.932 d =  0.024 Negligible 
Self-esteem 15.0 (2.0) 14.0 (4.0) U=235.5 0.291 d =  0.314 Small 
Belonging 16.0 (3.0) 16.0 (3.5) U=313  0.571 d = -0.163 Small 
Self-Efficacy for Exercise Scale    
Exercise Score 6.78 (2.86) 5.5(3.56) U=199.5 0.073 d = 0.531 Medium 
Key: † CAD n = 26, T2DM+CAD n= 21   ‡Cohen’s D calculated as the standardized mean difference based on ranks of CAD-T2DM.  The following social science 
guidelines for determining effect sizes were utilized; negligible r < 0.049 small effect size, r = 0.05 − 0.349; medium, r = 0.35 − 0.55 large, r = 0.56 or larger. 
74 
Table 5. Post-Rehabilitation program clinical characteristics for the total sample (n=48) and in subjects with coronary artery disease only 
(CAD, n=26) and with type II diabetes plus coronary artery disease (T2DM+CAD, n=22). 
Variables  All Subjects 
N = 48 
CAD 
n = 26 
T2DM + CAD 
n = 22 
Test 
Statistic 
p-value Odds Ratio 
(95% Confidence Interval) 
Hemoglobin A1C n (%)  
Normal < 6.4 mg/dl 
              Diabetes >6.4 mg/dl 
 
38 (79.2%) 
10(20.8%) 
 
25 (96.2%) 
1 (3.8%) 
 
13 (59.1%) 
9 (40.9%) 
X2(1)=9.93 0.002 ‡17.308 
(1.972-151.890) 
Hemoglobin A1C Range n (%)  
Normal < 5.7 mg/dl 
Pre-diabetes 5.71 -6.39 mg/dl  
Diabetes >6.4 mg/dl 
 
11 (22.9%) 
27 (56.3%) 
10 (20.8%) 
 
10 (38.5%) 
15 (57.7%) 
1 (3.8%) 
 
1(9.1%) 
12 (54.5%) 
9 (40.9%) 
X2(2)=13.9 
 
 
< 0.001 ‡8.000 
(0.894-71.578) 
§90.000 
(4.881-16.590) 
Body Mass Index n (%)  
 0-24.9 normal 
               > 25 abnormal 
 
8 (16.7%) 
40 (83.3%) 
 
6 (23.1%) 
20 (76.9%) 
 
2 (9.1%) 
20 (90.9%) 
X2(1)=1.68 0.195 ‡3.000 
(0.539-16.689) 
Body Mass Index Range n (%)  
 0-24.9 normal 
25-29.9 overweight 
> 30 obese 
 
8 (16.7%) 
19 (39.6%) 
21 (43.8%) 
 
6 (23.0%) 
8 (30.8%) 
12 (46.2%) 
 
2 (9.1%) 
11 (50.0%) 
9 (40.9%) 
X2(2)=2.59 0.274 ‡4.125 
(0.654-26.200) 
§2.250 
(0.365-13.870) 
Waist to Hip Radius Range n (%) 
Small risk <0.96 
High risk >0.96 
 
32 (66.7%) 
16 (33.3%) 
 
19 (73.1%) 
7 (26.9%) 
 
13 (59.1%) 
9 (40.9%) 
X2(1)=1.05 0.306 ‡1.879 
(0.558-6.326) 
‡=Reference category from first to second category  CAD-T2DM for calculating odds ratio., § = Reference category  first to third category for  CAD-T2DM for calculating 
odds ratio. . 
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Table 6. Group-specific descriptive and comparative statistics at pre and post rehabilitation program and the percentage of change over time 
for subjects with coronary artery disease only (CAD, n=26) and with type II diabetes plus coronary artery disease. 
 
  
Pre-Rehabilitation 
 
p-
value 
‡Cohen’s 
D 
 
 
Post-Rehabilitation 
 
p- 
value 
‡Cohen’s 
D 
 
% change Pre to Post 
(within the cohort) 
 
 
p-
value 
‡Cohen’s 
D 
Variables 
 
CAD 
n=26 
T2DM+CAD 
n=22 
  CAD 
n=26 
T2DM+CAD 
n=22 
  CAD 
n=26 
T2DM+CAD 
n=22 
  
Illness Severity  
Median (Interquartile Range) 
            
Hemoglobin A1C mg/dl 5.50 (0.50) 6.60 (0.97) 0.001 d=1.426 
 
5.8 (0.70) 6.35 (1.35) 0.001 d=1.512 
 
5.2% -3.8% 0.045 d=0.512 
Body mass index (%) 30.0 (7.40) 28.8 (7.62) 0.877 d=0.160 
 
29.1 (7.6) 28.6 (7.49) 0.975 d=0.066 
 
-3.1% -0.70% 0.473 d=0.063 
Waist to Hip Ratio (cm/in) 0.97 (0.11) 0.911(0.14) 0.717 d=0.469 
 
0.91 (0.09) 0.950 (0.14) 0.934 d=0.339 
 
-6.6% 4.1% 0.418 d=0.340 
Systolic Blood pressure mm/Hg 122 (25.0) 136 (23.0) 0.075 d=0.583 
 
118 (26.0) 129 (14.0) 0.073 d=0.529 
 
-3.4% -5.4% 0.432 d=0.527 
Diastolic Blood pressure mm/Hg 70 (16.0) 70 (19.0) 0.646 d=0 
 
66 (10.0) 70 (9.0) 0.247 d=0.420 
 
-6.1% 0% 0.356 d=0.421 
Jette Function Index Status 
Median (Interquartile Range) 
            
Assistance 0.139 (0.46) 0.167 (0.27) 0.867 d=0.074 
 
0.000 (0.14) 0.111 (0.35) 0.370 d=0.464 
 
0% -50.1% 0.530 d=0.416 
Pain 1.083 (0.38) 1.028 (0.42) 0.879 d=0.137 
 
1.083 (0.24) 1.056 (0.29) 0.703 d=0 
 
0% 2.7% 0.346 d=0.101 
Difficulty 1.111 (0.46) 1.028 (0.42) 0.410 d=0.186 
 
1.083 (0.28) 1.083 (0.35) 0.812 d=0 
 
-2.5% 5.1% 0.431 d=0.000 
Morisky Medication Adherence 
Score Mean(SD)          
 
0.654 (0.629) 
 
0.864 (0.940) 
 
0.203 
 
d=0.263 
 
 
0.654 (0.629) 
 
0.727(0.827) 
 
0.693 
 
d=0.099 
 
 
0% 
 
-18.7% 
 
0.918 
 
d=0.100 
Rehabilitation Appointments 
Attended  mean  (SD) 
Appointments Scheduled 
Appointments Attended 
 
 
24 (0) 
N/A 
 
 
24 (0) 
N/A 
  
 
d=0 
 
 
 
N/A 
20.4 (4.7) 
 
 
N/A 
21(2.9) 
  
 
d=0.154 
 
 
 
82.3% 
 
 
85.7% 
 
 
0.806 
 
 
 
d=0.154 
   ‡ Cohen’s D calculated as standardized mean difference based on ranks was computed as CAD-T2DM.   The following social science guidelines for determining effect sizes were utilized; 
negligible r < 0.049 small effect size, r = 0.05 − 0.349; medium, r = 0.35 − 0.55 large, r = 0.56 or larger.  
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6.0  RESEARCH RESULTS AND DISCUSSION: SPECIFIC AIM 4 
6.1 SPECIFIC AIM 4 PROGESS AND COMMITTEE DECISION  
 
 The focus of Specific Aim 4 was to explore the main and interaction effects of both the Patient 
Profiles and Illness Contextual Factors within the T2DM+CAD and CAD patients groups on 
Program Adherence and Outcomes upon conclusion of a standard outpatient cardiac 
rehabilitation program. 
  To accomplish this goal, the statistical plan was to perform bivariate correlations and simple 
linear regression between illness contextual factors, patient profile factors, and program 
adherence and outcome variables based on significant relationships noted in the bivariate 
analyses. Next, multiple regression analyses was to be conducted to explore the main effects and 
two-way and three-way interaction effects of Illness Contextual factors, Patient Profile factors, 
and diabetes status on program adherence and outcome variables. In addition, effect sizes 
(regression coefficient with 95% confidence intervals) were to be estimated for each main effect 
and interaction effect. R-square statistics would be calculated to summarize the percentage of 
variance explained in the program adherence and outcome variables. Finally, residual analyses 
were to be performed to identify instances of model misspecification and influential 
observations. 
  Since the outcome variables were categorical, and the predictor variables were either 
continuous or categorical, logistic regression was chosen as the primary method to test main, 
two-way and three-way interactions. 
  However, there were very few statistically significant findings in the univariate analyses, 
which was not unexpected based on the sample size. Therefore, the committee determined that it 
would be premature to attempt regression analysis and made the decision not to proceed further 
in this Aim until a larger sample is recruited in a follow-up study. 
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The protocol and consent forms, along with a brief progress report must be resubmitted at least one 
month prior to the renewal date noted above as required by FWA00006790 (University of Pittsburgh), 
FWA00006735 (University of Pittsburgh Medical Center), FWA00000600 (Children’s Hospital of 
Pittsburgh), FWA00003567 (Magee-Womens Health Corporation), FWA00003338 (University of 
Pittsburgh Medical Center Cancer Institute).  
Please be advised that your research study may be audited periodically by the University of 
Pittsburgh Research Conduct and Compliance Office. 
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